The largest bile duct. It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT.
Diseases of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.
Solid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER, resulting in the condition of CHOLELITHIASIS. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin.
Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure.
An imaging test of the BILIARY TRACT in which a contrast dye (RADIOPAQUE MEDIA) is injected into the BILE DUCT and x-ray pictures are taken.
An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.
Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.
Presence or formation of GALLSTONES in the COMMON BILE DUCT.
Passages external to the liver for the conveyance of bile. These include the COMMON BILE DUCT and the common hepatic duct (HEPATIC DUCT, COMMON).
Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
Tumors or cancer of the BILE DUCTS.
Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.
Excision of the gallbladder through an abdominal incision using a laparoscope.
Surgical removal of the GALLBLADDER.
Incision of Oddi's sphincter or Vater's ampulla performed by inserting a sphincterotome through an endoscope (DUODENOSCOPE) often following retrograde cholangiography (CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE). Endoscopic treatment by sphincterotomy is the preferred method of treatment for patients with retained or recurrent bile duct stones post-cholecystectomy, and for poor-surgical-risk patients that have the gallbladder still present.
Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.
Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.
Jaundice, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS.
Non-invasive diagnostic technique for visualizing the PANCREATIC DUCTS and BILE DUCTS without the use of injected CONTRAST MEDIA or x-ray. MRI scans provide excellent sensitivity for duct dilatation, biliary stricture, and intraductal abnormalities.
The sphincter of the hepatopancreatic ampulla within the duodenal papilla. The COMMON BILE DUCT and main pancreatic duct pass through this sphincter.
Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
The duct that is connected to the GALLBLADDER and allows the emptying of bile into the COMMON BILE DUCT.
Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
A dilation of the duodenal papilla that is the opening of the juncture of the COMMON BILE DUCT and the MAIN PANCREATIC DUCT, also known as the hepatopancreatic ampulla.
Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM.
Predominantly extrahepatic bile duct which is formed by the junction of the right and left hepatic ducts, which are predominantly intrahepatic, and, in turn, joins the cystic duct to form the common bile duct.
The BILE DUCTS and the GALLBLADDER.
Application of a ligature to tie a vessel or strangulate a part.
A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.
INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
Surgery of the smooth muscle sphincter of the hepatopancreatic ampulla to relieve blocked biliary or pancreatic ducts.
A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common.
Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.
Any surgical procedure performed on the biliary tract.
Surgical formation of an opening (stoma) into the COMMON BILE DUCT for drainage or for direct communication with a site in the small intestine, primarily the DUODENUM or JEJUNUM.
A benign tumor of the intrahepatic bile ducts.
The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
Instruments for the visual examination of interior structures of the body. There are rigid endoscopes and flexible fiberoptic endoscopes for various types of viewing in ENDOSCOPY.
Endoscopic examination, therapy or surgery of the luminal surface of the duodenum.
Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.
Diseases of the GALLBLADDER. They generally involve the impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, neoplasms, or other diseases.
A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
The destruction of a calculus of the kidney, ureter, bladder, or gallbladder by physical forces, including crushing with a lithotriptor through a catheter. Focused percutaneous ultrasound and focused hydraulic shock waves may be used without surgery. Lithotripsy does not include the dissolving of stones by acids or litholysis. Lithotripsy by laser is LITHOTRIPSY, LASER.
A benign neoplasm of muscle (usually smooth muscle) with glandular elements. It occurs most frequently in the uterus and uterine ligaments. (Stedman, 25th ed)
A radiopharmaceutical used extensively in cholescintigraphy for the evaluation of hepatobiliary diseases. (From Int Jrnl Rad Appl Inst 1992;43(9):1061-4)
The condition of an anatomical structure's being dilated beyond normal dimensions.
Endoscopic examination, therapy or surgery of the digestive tract.
Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.
Tumors or cancer of the gallbladder.
Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
Acute inflammation of the GALLBLADDER wall. It is characterized by the presence of ABDOMINAL PAIN; FEVER; and LEUKOCYTOSIS. Gallstone obstruction of the CYSTIC DUCT is present in approximately 90% of the cases.
The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.
Organic or functional motility disorder involving the SPHINCTER OF ODDI and associated with biliary COLIC. Pathological changes are most often seen in the COMMON BILE DUCT sphincter, and less commonly the PANCREATIC DUCT sphincter.
Surgical formation of an opening through the ABDOMINAL WALL into the JEJUNUM, usually for enteral hyperalimentation.
Presence or formation of GALLSTONES in the GALLBLADDER.
A bile pigment that is a degradation product of HEME.
The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.
Pathological processes of the PANCREAS.
The period during a surgical operation.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
Establishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum.
Retrograde bile flow. Reflux of bile can be from the duodenum to the stomach (DUODENOGASTRIC REFLUX); to the esophagus (GASTROESOPHAGEAL REFLUX); or to the PANCREAS.
Ultrasonography of internal organs using an ultrasound transducer sometimes mounted on a fiberoptic endoscope. In endosonography the transducer converts electronic signals into acoustic pulses or continuous waves and acts also as a receiver to detect reflected pulses from within the organ. An audiovisual-electronic interface converts the detected or processed echo signals, which pass through the electronics of the instrument, into a form that the technologist can evaluate. The procedure should not be confused with ENDOSCOPY which employs a special instrument called an endoscope. The "endo-" of endosonography refers to the examination of tissue within hollow organs, with reference to the usual ultrasonography procedure which is performed externally or transcutaneously.
Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.
Fragmentation of CALCULI, notably urinary or biliary, by LASER.
The condition of an anatomical structure's being constricted beyond normal dimensions.
Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests.
Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.
Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions.
Pathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).
A malignant tumor arising from the epithelium of the BILE DUCTS.
Tumors or cancer of the DUODENUM.
The largest lymphatic vessel that passes through the chest and drains into the SUBCLAVIAN VEIN.
An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.
FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cirrhosis involves the destruction of small intra-hepatic bile ducts and bile secretion. Secondary biliary cirrhosis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
An order of nematodes of the subclass SECERNENTEA. Its organisms possess two or three pairs of dorsolateral caudal papillae.
Hand-held tools or implements used by health professionals for the performance of surgical tasks.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
A condition characterized by the formation of CALCULI and concretions in the hollow organs or ducts of the body. They occur most often in the gallbladder, kidney, and lower urinary tract.
A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).
A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation that is commonly seen in infants. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.
Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.
A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.
An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.
A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site.
A pouch or sac developed from a tubular or saccular organ, such as the GASTROINTESTINAL TRACT.
An adenoma of the large intestine. It is usually a solitary, sessile, often large, tumor of colonic mucosa composed of mucinous epithelium covering delicate vascular projections. Hypersecretion and malignant changes occur frequently. (Stedman, 25th ed)
Radiography of the gallbladder after ingestion of a contrast medium.
Minute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries.
Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side.
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
Abdominal symptoms after removal of the GALLBLADDER. The common postoperative symptoms are often the same as those present before the operation, such as COLIC, bloating, NAUSEA, and VOMITING. There is pain on palpation of the right upper quadrant and sometimes JAUNDICE. The term is often used, inaccurately, to describe such postoperative symptoms not due to gallbladder removal.
An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
Liver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA.
Pathological processes of the LIVER.
Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed)
Any of the ducts which transport saliva. Salivary ducts include the parotid duct, the major and minor sublingual ducts, and the submandibular duct.
Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
A short thick vein formed by union of the superior mesenteric vein and the splenic vein.
A nontoxic radiopharmaceutical that is used in RADIONUCLIDE IMAGING for the clinical evaluation of hepatobiliary disorders in humans.
Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by a patient during the course of treatment.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
Linear TETRAPYRROLES that give a characteristic color to BILE including: BILIRUBIN; BILIVERDIN; and bilicyanin.
Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.
The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz.
The act of dilating.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Endoscopic surgical procedures performed with visualization via video transmission. When real-time video is combined interactively with prior CT scans or MRI images, this is called image-guided surgery (see SURGERY, COMPUTER-ASSISTED).
Hindrance of the passage of luminal contents in the DUODENUM. Duodenal obstruction can be partial or complete, and caused by intrinsic or extrinsic factors. Simple obstruction is associated with diminished or stopped flow of luminal contents. Strangulating obstruction is associated with impaired blood flow to the duodenum in addition to obstructed flow of luminal contents.
Hemorrhage in or through the BILIARY TRACT due to trauma, inflammation, CHOLELITHIASIS, vascular disease, or neoplasms.
A pair of excretory ducts of the middle kidneys (MESONEPHROI) of an embryo, also called mesonephric ducts. In higher vertebrates, Wolffian ducts persist in the male forming VAS DEFERENS, but atrophy into vestigial structures in the female.
Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.
The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic.
Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.
A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-.
Migration of a foreign body from its original location to some other location in the body.
A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum.
Measurement of the pressure or tension of liquids or gases with a manometer.
An abnormal passage communicating between any components of the digestive system, or between any part of the digestive system and surrounding organ(s).
Unanticipated information discovered in the course of testing or medical care. Used in discussions of information that may have social or psychological consequences, such as when it is learned that a child's biological father is someone other than the putative father, or that a person tested for one disease or disorder has, or is at risk for, something else.
A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed)
Disease having a short and relatively severe course.
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
A pair of ducts near the WOLFFIAN DUCTS in a developing embryo. In the male embryo, they degenerate with the appearance of testicular ANTI-MULLERIAN HORMONE. In the absence of anti-mullerian hormone, mullerian ducts give rise to the female reproductive tract, including the OVIDUCTS; UTERUS; CERVIX; and VAGINA.
A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.
The passage of viable bacteria from the GASTROINTESTINAL TRACT to extra-intestinal sites, such as the mesenteric lymph node complex, liver, spleen, kidney, and blood. Factors that promote bacterial translocation include overgrowth with gram-negative enteric bacilli, impaired host immune defenses, and injury to the INTESTINAL MUCOSA resulting in increased intestinal permeability. Bacterial translocation from the lung to the circulation is also possible and sometimes accompanies MECHANICAL VENTILATION.
Tumors or cancer of the DIGESTIVE SYSTEM.
Elements of limited time intervals, contributing to particular results or situations.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
Abnormal passage communicating with the PANCREAS.
Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.

Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation. (1/453)

Hepatic fibrosis or increased liver collagen contents drive functional abnormalities that, when extensive, may be life threatening. The purpose of this study was to assess the effects of the chronic stimulation or inhibition of nitric oxide synthesis in rats with hepatic fibrosis induced by permanent common bile duct ligation (3 weeks) and the role of expression of the different nitric oxide synthase isoforms. Bile duct ligation led to an important accumulation of collagen in the hepatic parenchyma, as shown both histologically and by the hydroxyproline contents of livers. Bilirubin and serum enzyme activities (measured as markers of cholestasis) increased several-fold after bile duct ligation. The area of fibrotic tissue, liver hydroxyproline content and serum markers of cholestasis were clearly related in obstructed rats. The absence of modifications in haemodynamic parameters excludes circulatory changes from being responsible for the development of liver alterations. In animals treated with NG-nitro-L-arginine methyl ester (L-NAME) the area of fibrosis was similar to that of untreated animals, the signs of cholestasis and cellular injury being more evident. In rats treated with L-arginine the area of fibrosis was almost three times larger than that found in bile duct ligated rats and in L-NAME-treated bile duct ligated rats, although the observed biochemical changes were similar to those seen in rats treated with L-NAME. Our results with inducible nitric oxide synthase, obtained by Western blots and immunohistochemistry, indicate a greater expression of the inducible enzyme in bile duct ligated and L-arginine-treated animals and a lower expression in the L-NAME and control groups. Constitutive nitric oxide synthase expression, obtained by Western blots, was very similar in all groups, except for the L-arginine-treated rats in which it was lower. These results suggest that nitric oxide production may be a key factor in the development of fibrosis in bile duct ligated rats. They also support the hypothesis of a dual role for nitric oxide; one beneficial, mediated by its circulatory effects, and the second negative, through its local toxic effects.  (+info)

Carcinoids of the common bile duct: a case report and literature review. (2/453)

Carcinoids of the extrahepatic bile ducts and particularly the common bile duct are extremely rare. A 65-year-old woman presented with obstructive jaundice. Laboratory and imaging studies gave results that were consistent with an obstructing lesion in the common bile duct. In this case, a stent was inserted initially to decompress the bile ducts. Subsequently a laparotomy and pancreaticoduodenectomy were performed and a tissue diagnosis of carcinoid of the common bile duct was made. The patient was well with no evidence of recurrence 17 months postoperatively. The authors believe this is the 19th reported case of an extrahepatic bile duct carcinoid.  (+info)

Spontaneous perforation of common bile duct in infants. (3/453)

Two infants with spontaneous perforation of the common bile duct are described. One presented with mild jaundice, dark urine, acholic stools, and hydroceles, the other with bilateral inguinal hernia. In both the diagnosis was unsuspected until bile-stained ascites was discovered. Both eventually developed bile-staining of the scrotum. Neither was acutely ill. The 131I-Rose Bengal faecal excretion test showed reduced faecal excretion at 8% and 12% of the injected dose with 16-5 and 17%/dl of the dose being recovered in the ascitic fluid 48 hours after intravenous injection. The ascitic:plasma ratio of isotope at that time was 32:1 and 28:1. Operative cholangiography in both showed a perforation at the junction of the cystic duct and common bile duct with no contrast entering the duodenum. Cholecystenterostomy using a Roux-en-Y loop of jejunum produced a rapid sustained recovery and is suggested as the treatment of choice. This condition should be considered in the differential diagnosis of obstructive jaundice in infancy since early surgical correction is necessary.  (+info)

Ultrasonographic evaluation of the common bile duct in biliary acute pancreatitis patients: comparison with endoscopic retrograde cholangiopancreatography. (4/453)

We compared the morphologic findings of the common bile duct by ultrasonography and endoscopic retrograde cholangiopancreatography in patients with biliary acute pancreatitis. Forty-five patients were studied. The diagnosis of acute pancreatitis was based on the presence of characteristic abdominal pain associated with an elevation of serum amylase and lipase concentrations. All patients underwent ultrasonography and subsequently urgent endoscopic retrograde cholangiopancreatography and eventually endoscopic sphincterotomy. Ultrasonography showed gallstones in 33 patients and sludge of the gallbladder in seven patients. In the common bile duct, lithiasis was found in two patients and sludge in 25. Endoscopic retrograde cholangiopancreatography showed choledocolithiasis in eight patients and sludge of the common bile duct in 32. In 27 cases (60%) concordance occurred between ultrasonographic and endoscopic retrograde cholangiopancreatographic detection of lithiasis or sludge of the common bile duct. The average diameter of the common bile duct determined by sonography was significantly smaller (P < 0.001) than that obtained by endoscopic retrograde cholangiopancreatography. The evaluation of this parameter indicated that a good correlation existed between the values obtained with the two techniques (r(s) = 0.765, P < 0.001). Both ultrasonography and endoscopic retrograde cholangiopancreatography can provide reliable measurements of the common bile duct diameter. Ultrasonography is the technique of choice in the initial investigation of patients with biliary acute pancreatitis.  (+info)

Role of angiotensin in renal sympathetic activation in cirrhotic rats. (5/453)

Central nervous system (CNS) renin-angiotensin activity influences the basal level of renal sympathetic nerve activity (RSNA) and its reflex regulation. The effect of type 1 angiotensin II (ANG II)-receptor antagonist treatment (losartan) on cardiac baroreflex regulation of RSNA and renal sodium handling was examined in rats with cirrhosis due to common bile duct ligation (CBDL). Basal levels of heart rate, mean arterial pressure (MAP), RSNA, and urinary sodium excretion were not affected by intracerebroventricular administration of either losartan or vehicle to CBDL rats. After acute intravenous isotonic saline loading (10% body wt) in vehicle-treated CBDL rats, MAP was unchanged and the decrease in RSNA seen in normal rats did not occur. However, in losartan-treated CBDL rats, there were significant concurrent but transient decreases in MAP (-20 +/- 2 mmHg) and RSNA (-25 +/- 3%). The natriuretic response to acute volume loading in losartan-treated CBDL rats was significantly less than that in vehicle-treated CBDL rats only at those time points where there were significant decreases in MAP. Antagonism of CNS ANG II type 1 receptors augments the renal sympathoinhibitory response to acute volume loading in CBDL. However, the natriuretic response to the acute volume loading is not improved, likely due to the strong antinatriuretic influence of the concomitant marked decrease in MAP (renal perfusion pressure) mediated by widespread sympathetic withdrawal from the systemic vasculature.  (+info)

Renal expression of aquaporins in liver cirrhosis induced by chronic common bile duct ligation in rats. (6/453)

Semiquantitative immunoblotting was used to investigate the expression levels of the four major renal aquaporins, the Na-K-2Cl cotransporter of the thick ascending limb, the type 3 Na-H exchanger, and the Na-K-ATPase in kidneys from rats with cirrhosis secondary to common bile duct ligation (CBDL). These rats had significant water retention and hyponatremia. In contrast to models of cirrhosis induced by carbon tetrachloride, aquaporin-2 expression in CBDL-induced cirrhosis was decreased. Thus, these results show that in the setting of extracellular fluid volume expansion, excessive water retention with hyponatremia can occur in the absence of increases in aquaporin-2 abundance. In addition, the expression levels of the two basolateral collecting duct aquaporins (aquaporin-3 and -4) were decreased in CBDL rats relative to sham-operated control rats. Similarly, the Na-K-2Cl cotransporter of the thick ascending limb and the type 3 Na-H exchanger showed decreases in expression. In contrast, the expression levels of aquaporin-1 and the all subunit of the Na-K-ATPase were not decreased. Thus, dysregulation of multiple water channels and ion transporters may play a role in water balance abnormalities associated with CBDL-induced cirrhosis in rats.  (+info)

Tissue plasminogen activator and plasminogen activator inhibitor-1 in human choledochal bile. (7/453)

Fibrinolytic properties have been detected in animal and human gallbladder (GB) bile. Plasminogen activator inhibitor-1 (PAI-1) has been reported in greater concentration in GB stone bile and may be a nucleating factor in the pathogenesis of GB stone formation. It is unknown whether or not human choledochal bile has similar properties, which could have a role in choledocholithiasis. The aims of this study were to determine the presence of fibrinolytic properties of human choledochal bile and to compare those properties among normal, acalculous, and calculous-infected choledochal bile. Tissue plasminogen activator (t-PA) and PAI-1 of choledochal bile were measured by enzyme linked immunosorbent assay in patients with cholangitis due to acalculous bile duct obstructions (n = 9), choledocholithiasis with cholangitis (n = 20), and normal bile (n = 7). The t-PA concentration of choledochal bile was no different among the three groups (acalculous-infected bile, median 4.61 ng/ml, and calculous-infected bile, 4.61 ng/ml, versus normal bile, 7.33 ng/ml). PAI-1 was detected in choledochal bile in significantly greater concentrations in patients with acalculous cholangitis due to bile duct obstructions and choledocholithiasis with cholangitis (acalculous-infected bile, median 0.36 ng/ml, and calculous-infected bile, 0.1 ng/ml, versus normal bile, 0.02 ng/ml, p < 0.05), but the bile concentration of PAI-1 was no different between the acalculous and calculous-infected choledochal bile. Human choledochal bile possesses t-PA and PAI-1. PAI-1 was present in greater concentrations in both acalculous and calculous-infected choledochal bile. Increased levels of PAI-1 may be an epiphenomenon of cholangitis rather than a factor in the pathogenesis of choledocholithiasis.  (+info)

Roux-en-Y hepaticojejunostomy: a reappraisal of its indications and results. (8/453)

A critical evaluation is made of 131 patients submitted to choledocho or hepaticojejunostomy. The main indications for hepaticojejunostomy were iatrogenic strictures of CBD (60 patients), and choledocholithiasis with markedly dilated duct (41 patients). The overall mortality rate was 4% representing principally renal hepatic failure, bile peritonitis and bleeding. The complications following hepaticojejunostomy included only in one case biliary fistula which required reoperation. The long-term results of 80 patients available for a followup study were as follows: 63 patients (78.7%) were symptom-free at 2-13 years followup; 8 patients had brief episodes of cholangitis which responded to antibiotic and corticosteroid treatment; 9 patients required reoperation for stricture of anastomosis. These overall results are a strong argument for hepaticojejunostomy which, compared with choledochoduodenostomy, avoids the hazards of the so-called sump syndrome and of the reflux of enteric contents in the CBD. An increased incidence of peptic ulcer disease in the patients submitted to hepaticojejunostomy was not observed. In very high strictures and in reinterventions anastomosis between left hepatic duct and Roux-en-Y jejunal limb was carried out. The results achieved with this technique, which was performed in 26 patients, were about the same following hepaticojejunostomy.  (+info)

Examples:

1. Gallstones: Small, pebble-like deposits that form in the gallbladder or bile ducts and can cause blockages and inflammation.
2. Cholangitis: An infection of the bile ducts that can cause fever, chills, and abdominal pain.
3. Bile duct cancer: A type of cancer that affects the cells lining the bile ducts.
4. Stricture: A narrowing of the bile duct that can cause obstruction and block the flow of bile.
5. Cysts: Fluid-filled sacs that can form in the bile ducts and cause symptoms such as abdominal pain and jaundice.

Gallstones can be made of cholesterol, bilirubin, or other substances found in bile. They can cause a variety of symptoms, including:

* Abdominal pain (often in the upper right abdomen)
* Nausea and vomiting
* Fever
* Yellowing of the skin and eyes (jaundice)
* Tea-colored urine
* Pale or clay-colored stools

Gallstones can be classified into several types based on their composition, size, and location. The most common types are:

* Cholesterol gallstones: These are the most common type of gallstone and are usually yellow or green in color. They are made of cholesterol and other substances found in bile.
* Pigment gallstones: These stones are made of bilirubin, a yellow pigment found in bile. They are often smaller than cholesterol gallstones and may be more difficult to detect.
* Mixed gallstones: These stones are a combination of cholesterol and pigment gallstones.

Gallstones can cause a variety of complications, including:

* Gallbladder inflammation (cholecystitis)
* Infection of the bile ducts (choledochalitis)
* Pancreatitis (inflammation of the pancreas)
* Blockage of the common bile duct, which can cause jaundice and infection.

Treatment for gallstones usually involves surgery to remove the gallbladder, although in some cases, medications may be used to dissolve small stones. In severe cases, emergency surgery may be necessary to treat complications such as inflammation or infection.

Examples of bile duct diseases include:

1. Primary sclerosing cholangitis (PSC): An inflammatory condition that damages the bile ducts, leading to scarring and narrowing of the ducts.
2. Cholangiocarcinoma: A type of cancer that originates in the bile ducts.
3. Gallstones: Small, pebble-like deposits that form in the gallbladder or bile ducts and can cause blockages and inflammation.
4. Bile duct injuries: Damage to the bile ducts during surgery or other medical procedures.
5. Biliary atresia: A congenital condition where the bile ducts are blocked or absent, leading to jaundice and other symptoms in infants.

Treatment for bile duct diseases depends on the underlying cause and can include medications, endoscopic procedures, surgery, and in some cases, liver transplantation.

The term choledocholithiasis is derived from the Greek words "chole" meaning bile, "dochos" meaning duct, and "-iasis" meaning condition or disease. It is used to describe a specific type of gallstone that forms within the common bile duct, rather than in the gallbladder or liver.

Choledocholithiasis can be caused by a variety of factors, including genetic predisposition, inflammation of the bile ducts (cholangitis), and blockages within the ducts. Treatment options for choledocholithiasis include endoscopic therapy, surgery, and medications to dissolve the gallstones.

In summary, choledocholithiasis is a condition characterized by the presence of gallstones in the common bile duct, which can cause a range of symptoms and may require medical intervention to treat.

There are several types of cholestasis, including:

1. Obstructive cholestasis: This occurs when there is a blockage in the bile ducts, preventing bile from flowing freely from the liver.
2. Metabolic cholestasis: This is caused by a problem with the metabolism of bile acids in the liver.
3. Inflammatory cholestasis: This occurs when there is inflammation in the liver, which can cause scarring and impair bile flow.
4. Idiopathic cholestasis: This type of cholestasis has no identifiable cause.

Treatment for cholestasis depends on the underlying cause, but may include medications to improve bile flow, dissolve gallstones, or reduce inflammation. In severe cases, a liver transplant may be necessary. Early diagnosis and treatment can help to manage symptoms and prevent complications of cholestasis.

Bile duct neoplasms refer to abnormal growths or tumors that occur in the bile ducts, which are the tubes that carry bile from the liver and gallbladder to the small intestine. Bile duct neoplasms can be benign (non-cancerous) or malignant (cancerous).

Types of Bile Duct Neoplasms:

There are several types of bile duct neoplasms, including:

1. Bile duct adenoma: A benign tumor that grows in the bile ducts.
2. Bile duct carcinoma: A malignant tumor that grows in the bile ducts and can spread to other parts of the body.
3. Cholangiocarcinoma: A rare type of bile duct cancer that originates in the cells lining the bile ducts.
4. Gallbladder cancer: A type of cancer that occurs in the gallbladder, which is a small organ located under the liver that stores bile.

Causes and Risk Factors:

The exact cause of bile duct neoplasms is not known, but there are several risk factors that may increase the likelihood of developing these tumors, including:

1. Age: Bile duct neoplasms are more common in people over the age of 50.
2. Gender: Women are more likely to develop bile duct neoplasms than men.
3. Family history: People with a family history of bile duct cancer or other liver diseases may be at increased risk.
4. Previous exposure to certain chemicals: Exposure to certain chemicals, such as thorium, has been linked to an increased risk of developing bile duct neoplasms.

Symptoms:

The symptoms of bile duct neoplasms can vary depending on the location and size of the tumor. Some common symptoms include:

1. Yellowing of the skin and eyes (jaundice)
2. Fatigue
3. Loss of appetite
4. Nausea and vomiting
5. Abdominal pain or discomfort
6. Weight loss
7. Itching all over the body
8. Dark urine
9. Pale stools

Diagnosis:

Diagnosis of bile duct neoplasms typically involves a combination of imaging tests and biopsy. The following tests may be used to diagnose bile duct neoplasms:

1. Ultrasound: This non-invasive test uses high-frequency sound waves to create images of the liver and bile ducts.
2. Computed tomography (CT) scan: This imaging test uses X-rays and computer technology to create detailed images of the liver and bile ducts.
3. Magnetic resonance imaging (MRI): This test uses a strong magnetic field and radio waves to create detailed images of the liver and bile ducts.
4. Endoscopic ultrasound: This test involves inserting an endoscope (a thin, flexible tube with a small ultrasound probe) into the bile ducts through the mouth or stomach to obtain images and samples of the bile ducts.
5. Biopsy: A biopsy may be performed during an endoscopic ultrasound or during surgery to remove the tumor. The sample is then examined under a microscope for cancer cells.

Treatment:

The treatment of bile duct neoplasms depends on several factors, including the type and stage of the cancer, the patient's overall health, and the patient's preferences. The following are some common treatment options for bile duct neoplasms:

1. Surgery: Surgery may be performed to remove the tumor or a portion of the bile duct. This may involve a Whipple procedure (a surgical procedure to remove the head of the pancreas, the gallbladder, and a portion of the bile duct), a bile duct resection, or a liver transplant.
2. Chemotherapy: Chemotherapy may be used before or after surgery to shrink the tumor and kill any remaining cancer cells.
3. Radiation therapy: Radiation therapy may be used to destroy cancer cells that cannot be removed by surgery or to relieve symptoms such as pain or blockage of the bile duct.
4. Stent placement: A stent may be placed in the bile duct to help keep it open and improve blood flow to the liver.
5. Ablation therapy: Ablation therapy may be used to destroy cancer cells by freezing or heating them with a probe inserted through an endoscope.
6. Targeted therapy: Targeted therapy may be used to treat certain types of bile duct cancer, such as cholangiocarcinoma, by targeting specific molecules that promote the growth and spread of the cancer cells.
7. Clinical trials: Clinical trials are research studies that evaluate new treatments for bile duct neoplasms. These may be an option for patients who have not responded to other treatments or who have advanced cancer.

The term "extrahepatic" refers to the fact that the obstruction occurs outside of the liver, as opposed to intrahepatic cholestasis, which occurs within the liver. Extrahepatic cholestasis can be caused by a variety of factors, including gallstones, pancreatitis, and cancer.

Treatment for extrahepatic cholestasis typically involves addressing the underlying cause of the obstruction. In some cases, this may involve surgery to remove the blockage or other procedures such as stent placement or biliary bypass surgery. Medications such as bile salts and ursodeoxycholic acid may also be used to help improve liver function and reduce symptoms.

In summary, extrahepatic cholestasis is a type of bile duct obstruction that occurs outside of the liver, leading to bile buildup in the bloodstream and potentially causing a range of symptoms. Treatment typically involves addressing the underlying cause of the obstruction.

Types of Cholangitis:
There are two types of cholangitis:

1. Acute cholangitis: This type of cholangitis occurs suddenly and is usually caused by a blockage in the bile ducts, such as a gallstone or a tumor.
2. Chronic cholangitis: This type of cholangitis develops gradually over time and can be caused by recurring inflammation or scarring of the bile ducts.

Causes and Risk Factors:
The most common cause of cholangitis is a blockage in the bile ducts, which allows bacteria to grow and multiply, leading to infection. Other causes include:

* Gallstones
* Tumors
* Pancreatitis (inflammation of the pancreas)
* Trauma to the abdomen
* Inflammatory bowel disease
* HIV/AIDS
* Cancer

Symptoms:
The symptoms of cholangitis can vary depending on the severity of the infection, but may include:

* Fever
* Chills
* Abdominal pain
* Yellowing of the skin and eyes (jaundice)
* Dark urine
* Pale stools
* Nausea and vomiting

Diagnosis:
Cholangitis is diagnosed through a combination of imaging tests, such as CT scans or endoscopic ultrasound, and laboratory tests to determine the presence of infection. A liver biopsy may also be performed to confirm the diagnosis.

Treatment:
The treatment of cholangitis depends on the cause and severity of the infection, but may include:

* Antibiotics to treat bacterial or fungal infections
* Supportive care, such as fluids and nutrition, to manage symptoms
* Surgical drainage of the bile ducts to relieve blockages
* Endoscopic therapy, such as stent placement or laser lithotripsy, to remove gallstones or other obstructions
* Liver transplantation in severe cases

Prognosis:
The prognosis for cholangitis depends on the severity of the infection and the underlying cause. If treated promptly and effectively, the prognosis is generally good. However, if left untreated or if there are complications, the prognosis can be poor.

Prevention:
Preventing cholangitis involves managing any underlying conditions that may increase the risk of infection, such as gallstones or liver disease. Other preventive measures include:

* Practicing good hygiene, such as washing hands regularly
* Avoiding sharing of needles or other drug paraphernalia
* Avoiding close contact with people who are sick
* Getting vaccinated against infections that can cause cholangitis
* Managing any underlying medical conditions, such as diabetes or liver disease

Complications:
Cholangitis can lead to several complications, including:

* Bile duct damage, which can lead to bile leaking into the abdomen and causing an infection called peritonitis
* Spread of the infection to other parts of the body, such as the bloodstream or lungs
* Sepsis, a severe and life-threatening reaction to the infection
* Organ failure, particularly liver and kidney failure
* Death

It is important to seek medical attention promptly if you experience any symptoms of cholangitis, as early treatment can help prevent complications and improve outcomes.

Cholelithiasis is a common condition that affects millions of people worldwide. It can occur at any age but is more common in adults over 40 years old. Women are more likely to develop cholelithiasis than men, especially during pregnancy or after childbirth.

The symptoms of cholelithiasis can vary depending on the size and location of the gallstones. Some people may not experience any symptoms at all, while others may have:

* Abdominal pain, especially in the upper right side of the abdomen
* Nausea and vomiting
* Fever
* Shaking or chills
* Loss of appetite
* Yellowing of the skin and eyes (jaundice)

If left untreated, cholelithiasis can lead to complications such as inflammation of the gallbladder (cholangitis), infection of the bile ducts (biliary sepsis), or blockage of the common bile duct. These complications can be life-threatening and require immediate medical attention.

The diagnosis of cholelithiasis is usually made through a combination of imaging tests such as ultrasound, CT scan, or MRI, and blood tests to check for signs of inflammation and liver function. Treatment options for cholelithiasis include:

* Watchful waiting: If the gallstones are small and not causing any symptoms, doctors may recommend monitoring the condition without immediate treatment.
* Medications: Oral medications such as bile salts or ursodiol can dissolve small gallstones and relieve symptoms.
* Laparoscopic cholecystectomy: A minimally invasive surgical procedure to remove the gallbladder through small incisions.
* Open cholecystectomy: An open surgery to remove the gallbladder, usually performed when the gallstones are large or there are other complications.

It is important to seek medical attention if you experience any symptoms of cholelithiasis, as early diagnosis and treatment can help prevent complications and improve outcomes.

There are several types of biliary tract diseases, including:

1. Gallstones: Small, pebble-like deposits that form in the gallbladder and can cause pain and blockages.
2. Cholangitis: An infection of the bile ducts that can cause fever, chills, and abdominal pain.
3. Biliary cirrhosis: Scarring of the liver and bile ducts that can lead to liver failure.
4. Pancreatitis: Inflammation of the pancreas that can cause abdominal pain and digestive problems.
5. Cancer of the biliary tract: Cancer that affects the liver, gallbladder, or bile ducts.

Biliary tract diseases can be caused by a variety of factors, including genetics, obesity, alcohol consumption, and certain medications. Diagnosis is typically made through a combination of imaging tests, such as CT scans and endoscopic ultrasound, and laboratory tests, such as blood tests and liver function tests.

Treatment for biliary tract diseases depends on the underlying cause and severity of the condition. In some cases, treatment may involve medications to dissolve gallstones or treat infections. In more severe cases, surgery may be necessary to remove the gallbladder or repair damaged bile ducts.

Prevention is key in avoiding biliary tract diseases, and this includes maintaining a healthy diet and lifestyle, managing risk factors such as obesity and alcohol consumption, and getting regular medical check-ups. Early detection and treatment of biliary tract diseases can help to improve outcomes and reduce the risk of complications.

There are several causes of pancreatitis, including:

1. Gallstones: These can block the pancreatic duct, causing inflammation.
2. Alcohol consumption: Heavy alcohol use can damage the pancreas and lead to inflammation.
3. High triglycerides: Elevated levels of triglycerides in the blood can cause pancreatitis.
4. Infections: Viral or bacterial infections can infect the pancreas and cause inflammation.
5. Genetic factors: Some people may be more susceptible to pancreatitis due to inherited genetic mutations.
6. Pancreatic trauma: Physical injury to the pancreas can cause inflammation.
7. Certain medications: Some medications, such as certain antibiotics and chemotherapy drugs, can cause pancreatitis as a side effect.

Symptoms of pancreatitis may include:

1. Abdominal pain
2. Nausea and vomiting
3. Fever
4. Diarrhea or bloating
5. Weight loss
6. Loss of appetite

Treatment for pancreatitis depends on the underlying cause and the severity of the condition. In some cases, hospitalization may be necessary to manage symptoms and address any complications. Treatment options may include:

1. Pain management: Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids may be used to manage abdominal pain.
2. Fluid replacement: Intravenous fluids may be given to replace lost fluids and electrolytes.
3. Antibiotics: If the pancreatitis is caused by an infection, antibiotics may be prescribed to treat the infection.
4. Nutritional support: Patients with pancreatitis may require nutritional support to ensure they are getting enough calories and nutrients.
5. Pancreatic enzyme replacement therapy: In some cases, pancreatic enzyme replacement therapy may be necessary to help the body digest food.
6. Surgery: In severe cases of pancreatitis, surgery may be necessary to remove damaged tissue or repair damaged blood vessels.

It is important to seek medical attention if you experience persistent abdominal pain or other symptoms of pancreatitis, as early treatment can help prevent complications and improve outcomes.

The exact cause of choledochal cysts is not well understood, but they are believed to result from developmental abnormalities during fetal life. In some cases, there may be associated genetic mutations or other congenital anomalies. The diagnosis of a choledochal cyst is typically made using imaging studies such as ultrasound, CT scan, or MRI, and the cyst may be removed surgically if it causes symptoms or if it becomes infected.

There are several types of choledochal cysts, including:

1. Type I: This is the most common type, where the cyst is located near the liver and has a distinctive "dome-shaped" appearance.
2. Type II: This type is located near the pancreas and has a more irregular shape.
3. Type III: This type is located near the gallbladder and has a small opening into the bile duct.
4. Type IV: This type is located further down the bile duct and has no opening into the duct.

Choledochal cysts are relatively rare, occurring in approximately 1 in 250,000 to 1 in 500,000 live births. They can be associated with other congenital anomalies such as polycystic kidney disease, Turner syndrome, and Down syndrome. The surgical removal of a choledochal cyst is typically curative, but long-term follow-up is often necessary to monitor for potential complications such as bile duct stricture or cancer.

The most common types of biliary fistulas are:

1. Bile duct-enteric fistula: This type of fistula connects the bile ducts to the small intestine.
2. Bile duct-skin fistula: This type of fistula connects the bile ducts to the skin, which can lead to a bile leak and infection.
3. Bile duct-liver fistula: This type of fistula connects the bile ducts to the liver, which can cause bleeding and infection.

Symptoms of biliary fistula may include:

* Jaundice (yellowing of the skin and whites of the eyes)
* Pale or clay-colored stools
* Dark urine
* Fatigue
* Loss of appetite
* Weight loss

Diagnosis of biliary fistula is typically made through a combination of imaging tests such as endoscopy, CT scan, and MRI. Treatment options for biliary fistula include:

1. Endoscopic therapy: This may involve the use of an endoscope to repair or close off the fistula.
2. Surgery: In some cases, surgery may be necessary to repair or remove the damaged bile ducts.
3. Stent placement: A stent may be placed in the bile ducts to help keep them open and allow for proper drainage.

It is important to seek medical attention if you experience any symptoms of biliary fistula, as it can lead to serious complications such as infection or bleeding.

Prevalence: Adenomas account for approximately 10% to 20% of all primary liver tumors.

Risk Factors: Risk factors for developing adenoma include age (>60 years old), cirrhosis, and a family history of hepatocellular carcinoma or polycystic liver disease.

Pathology: Adenomas are typically slow-growing and may not cause symptoms in the early stages. They can grow large enough to obstruct bile flow and cause abdominal pain, jaundice, and pruritus.

Diagnosis: Adenomas are diagnosed via imaging studies such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). Endoscopic ultrasound may also be used to evaluate the tumor and assess for invasive features.

Treatment: Surgical resection is the primary treatment for adenomas. In some cases, liver transplantation may be considered if the tumor is large or multiple and surgical resection is not feasible. Ablation therapies such as radiofrequency ablation or chemoembolization may also be used to control symptoms and slow tumor growth.

Prognosis: The prognosis for patients with adenoma is generally good, with a 5-year survival rate of approximately 90%. However, the risk of malignant transformation (cancer) is present, particularly in cases where there are multiple adenomas or invasive features.

In conclusion, adenoma of the bile ducts is a benign tumor that can occur within the liver. While the prognosis is generally good, early detection and treatment are important to prevent complications and minimize the risk of malignant transformation.

Cholecystitis can be acute or chronic. Acute cholecystitis occurs when the gallbladder becomes inflamed suddenly, usually due to a blockage in the bile ducts. This can cause symptoms such as abdominal pain, nausea, vomiting, and fever. Chronic cholecystitis is a long-standing inflammation of the gallbladder that can lead to scarring and thickening of the gallbladder wall.

The causes of cholecystitis include:

1. Gallstones: The most common cause of cholecystitis is the presence of gallstones in the gallbladder. These stones can block the bile ducts and cause inflammation.
2. Infection: Bacterial infection can spread to the gallbladder from other parts of the body, causing cholecystitis.
3. Pancreatitis: Inflammation of the pancreas can spread to the gallbladder and cause cholecystitis.
4. Incomplete emptying of the gallbladder: If the gallbladder does not empty properly, bile can become stagnant and cause inflammation.
5. Genetic factors: Some people may be more susceptible to developing cholecystitis due to genetic factors.

Symptoms of cholecystitis may include:

1. Abdominal pain, especially in the upper right side of the abdomen
2. Nausea and vomiting
3. Fever
4. Loss of appetite
5. Jaundice (yellowing of the skin and eyes)
6. Tea-colored urine
7. Pale or clay-colored stools

If you suspect that you or someone else may have cholecystitis, it is important to seek medical attention immediately. A healthcare provider can diagnose cholecystitis based on a physical examination, medical history, and results of diagnostic tests such as an ultrasound or CT scan. Treatment for cholecystitis usually involves antibiotics to clear up any infection, and in severe cases, surgery to remove the gallbladder may be necessary.

Here are some additional details about each of the gallbladder diseases mentioned in the definition:

* Gallstone disease: This is the most common gallbladder disease and occurs when small stones form in the gallbladder. The stones can be made of cholesterol, bilirubin, or other substances. They can cause pain, inflammation, and infection if left untreated.
* Cholecystitis: This is inflammation of the gallbladder that can occur when gallstones block the ducts and cause bile to build up. Symptoms can include abdominal pain, fever, and chills. If left untreated, cholecystitis can lead to more serious complications such as gangrene or perforation of the gallbladder.
* Choledocholithiasis: This is the presence of stones in the bile ducts that carry bile from the liver and gallbladder to the small intestine. These stones can cause blockages and lead to inflammation, infection, and damage to the liver and pancreas.
* Pancreatitis: This is inflammation of the pancreas that can occur when the pancreatic ducts become blocked by gallstones or other substances. Symptoms can include abdominal pain, nausea, vomiting, and fever. If left untreated, pancreatitis can lead to serious complications such as infection, organ failure, and death.
* Gallbladder cancer: This is a rare but aggressive type of cancer that occurs in the gallbladder. Symptoms can include abdominal pain, jaundice, and weight loss. If left untreated, gallbladder cancer can spread to other parts of the body and lead to death.

Overall, these gallbladder diseases can have a significant impact on quality of life and can be fatal if left untreated. It is important to seek medical attention if symptoms persist or worsen over time.

Jaundice is typically diagnosed through physical examination and laboratory tests such as blood tests to measure bilirubin levels. Treatment depends on the underlying cause, but may include medications to reduce bilirubin production or increase its excretion, or surgery to remove blockages in the bile ducts.

Here are some of the synonyms for Jaundice:

1. Yellow fever
2. Yellow jaundice
3. Hepatitis
4. Gallstones
5. Cholestasis
6. Obstruction of the bile ducts
7. Biliary tract disease
8. Hemochromatosis
9. Sickle cell anemia
10. Crigler-Najjar syndrome

Here are some of the antonyms for Jaundice:

1. Pinkness
2. Normal skin color
3. Healthy liver function
4. Bilirubin levels within normal range
5. No signs of liver disease or obstruction of bile ducts.

The term "adenomyoma" is derived from the Greek words "adene," meaning gland, and "omyoma," meaning tumor. This refers to the fact that these tumors are made up of glandular tissue, which is responsible for the production of mucus and other fluids in the body.

Adenomyomas are typically slow-growing and may not cause any symptoms in their early stages. However, they can eventually become large enough to cause abdominal pain, heavy menstrual bleeding, and other problems. If left untreated, adenomyomas can become cancerous over time, so it is important to seek medical attention if you suspect you may have one.

Treatment options for adenomyoma include hysterectomy (removal of the uterus), endometrial ablation (destruction of the uterine lining), and medications to shrink the tumor. In some cases, a minimally invasive procedure called a laparoscopy may be used to remove the tumor.

In summary, adenomyoma is a type of benign tumor that develops in the muscular layer of the uterus and can cause abdominal pain, heavy menstrual bleeding, and other symptoms. It is important to seek medical attention if you suspect you may have an adenomyoma to prevent it from becoming cancerous over time.

There are many different causes of pathological dilatation, including:

1. Infection: Infections like tuberculosis or abscesses can cause inflammation and swelling in affected tissues, leading to dilatation.
2. Inflammation: Inflammatory conditions like rheumatoid arthritis or Crohn's disease can cause dilatation of blood vessels and organs.
3. Heart disease: Conditions like heart failure or coronary artery disease can lead to dilatation of the heart chambers or vessels.
4. Liver or spleen disease: Dilatation of the liver or spleen can occur due to conditions like cirrhosis or splenomegaly.
5. Neoplasms: Tumors can cause dilatation of affected structures, such as blood vessels or organs.

Pathological dilatation can lead to a range of symptoms depending on the location and severity of the condition. These may include:

1. Swelling or distension of the affected structure
2. Pain or discomfort in the affected area
3. Difficulty breathing or swallowing (in the case of dilatation in the throat or airways)
4. Fatigue or weakness
5. Pale or clammy skin
6. Rapid heart rate or palpitations
7. Shortness of breath (dyspnea)

Diagnosis of pathological dilatation typically involves a combination of physical examination, imaging studies like X-rays or CT scans, and laboratory tests to identify the underlying cause. Treatment depends on the specific condition and may include medications, surgery, or other interventions to address the underlying cause and relieve symptoms.

Types of Gallbladder Neoplasms:

1. Adenoma: A benign tumor that grows in the gallbladder wall and can become malignant over time if left untreated.
2. Cholangiocarcinoma: A rare and aggressive malignant tumor that arises in the gallbladder or bile ducts.
3. Gallbladder cancer: A general term used to describe any type of cancer that develops in the gallbladder, including adenocarcinoma, squamous cell carcinoma, and other rare types.

Causes and Risk Factors:

1. Genetics: A family history of gallbladder disease or certain genetic conditions can increase the risk of developing gallbladder neoplasms.
2. Chronic inflammation: Long-standing inflammation in the gallbladder, such as that caused by gallstones or chronic bile duct obstruction, can increase the risk of developing cancer.
3. Obesity: Being overweight or obese may increase the risk of developing gallbladder neoplasms.
4. Age: The risk of developing gallbladder neoplasms increases with age, with most cases occurring in people over the age of 50.

Symptoms and Diagnosis:

1. Abdominal pain: Pain in the upper right abdomen is a common symptom of gallbladder neoplasms.
2. Jaundice: Yellowing of the skin and eyes can occur if the cancer blocks the bile ducts.
3. Weight loss: Unexplained weight loss can be a symptom of some types of gallbladder neoplasms.
4. Fatigue: Feeling tired or weak can be a symptom of some types of gallbladder neoplasms.

Diagnosis is typically made through a combination of imaging tests such as CT scans, MRI scans, and PET scans, and a biopsy to confirm the presence of cancer cells.

Treatment:

1. Surgery: Surgery is the primary treatment for gallbladder neoplasms. The type of surgery depends on the stage and location of the cancer.
2. Chemotherapy: Chemotherapy may be used in combination with surgery to treat advanced or aggressive cancers.
3. Radiation therapy: Radiation therapy may be used in combination with surgery to treat advanced or aggressive cancers.
4. Watchful waiting: For early-stage cancers, a wait-and-watch approach may be taken, where the patient is monitored regularly with imaging tests to see if the cancer progresses.

Prognosis:
The prognosis for gallbladder neoplasms depends on the stage and location of the cancer at the time of diagnosis. In general, the earlier the cancer is detected and treated, the better the prognosis. For early-stage cancers, the 5-year survival rate is high, while for advanced cancers, the prognosis is poor.

Complications:

1. Bile duct injury: During surgery, there is a risk of damaging the bile ducts, which can lead to complications such as bile leakage or bleeding.
2. Infection: There is a risk of infection after surgery, which can be serious and may require hospitalization.
3. Pancreatitis: Gallbladder cancer can cause inflammation of the pancreas, leading to pancreatitis.
4. Jaundice: Cancer of the gallbladder can block the bile ducts, leading to jaundice and other complications.
5. Spread of cancer: Gallbladder cancer can spread to other parts of the body, such as the liver or lymph nodes, which can reduce the chances of a cure.

Inflammation of the gallbladder that develops rapidly and usually as a result of obstruction of the cystic duct by a gallstone or rarely by tumors, parasites, or external pressure. Symptoms include right upper quadrant abdominal pain, fever, nausea, vomiting, and Murphy's sign (tenderness over the gallbladder). Treatment is with antibiotics, analgesics, and supportive care; surgical intervention may be required in severe cases or if there are complications. See: biliary colic; cholelithiasis; cholangitis.

The sphincter of Oddi is a ring-like muscle that controls the opening and closing of the common bile duct into the small intestine. Sphincter of Oddi dysfunction refers to problems with the functioning of this muscle, which can lead to a range of symptoms including abdominal pain, nausea, vomiting, and jaundice (yellowing of the skin and eyes).

There are several possible causes of sphincter of Oddi dysfunction, including:

1. Gallstones: Gallstones can block the common bile duct and cause inflammation and scarring of the sphincter, leading to dysfunction.
2. Inflammatory conditions: Conditions such as pancreatitis and cholangitis can cause inflammation and damage to the sphincter muscle.
3. Cancer: Bile duct cancer or pancreatic cancer can infiltrate and damage the sphincter muscle, leading to dysfunction.
4. Injury: Trauma to the abdomen or surgical damage to the bile ducts can cause dysfunction of the sphincter.
5. Neurological disorders: Certain neurological conditions such as Parkinson's disease, multiple sclerosis, and peripheral neuropathy can affect the nerves that control the sphincter muscle, leading to dysfunction.

The symptoms of sphincter of Oddi dysfunction can vary depending on the underlying cause and the severity of the dysfunction. They may include:

* Abdominal pain, often in the right upper quadrant or middle of the abdomen
* Nausea and vomiting
* Jaundice (yellowing of the skin and eyes)
* Fatigue
* Loss of appetite
* Weight loss
* Pale or clay-colored stools
* Dark urine

If you are experiencing any of these symptoms, it is important to seek medical attention as soon as possible. A healthcare professional can perform a series of tests to diagnose the underlying cause of the dysfunction and develop an appropriate treatment plan. These tests may include:

1. Endoscopy: A thin, flexible tube with a camera and light on the end is inserted through the mouth and into the bile ducts to visualize the sphincter and surrounding tissues.
2. Imaging tests: Such as X-rays, CT scans, or MRI scans to evaluate the structure of the bile ducts and liver.
3. Blood tests: To check for signs of liver damage or pancreas inflammation.
4. ERCP (endoscopic retrograde cholangiopancreatography): A procedure in which a flexible tube with a camera and a special tool is inserted through the mouth and into the bile ducts to diagnose and treat problems.
5. Sphincterotomy: A procedure in which the surgeon makes a small incision in the sphincter muscle to relieve pressure and allow normal flow of bile.
6. Stent placement: A small tube is placed inside the bile duct to keep it open and improve flow.
7. Biliary bypass surgery: A procedure in which the surgeon reroutes the bile flow around the blocked bile duct.
8. Liver transplantation: In severe cases of bile duct injuries, a liver transplant may be necessary.

It is important to note that the treatment plan will depend on the underlying cause of the dysfunction and the severity of the condition. A healthcare professional will be able to determine the best course of treatment based on individual circumstances.

There are several types of cholecystolithiasis:

* Pigmented stones (made from bilirubin)
* Cholesterol stones (made from cholesterol and other substances in the bile)
* Mixed stones (a combination of pigmented and cholesterol stones)

Symptoms:

* Abdominal pain (especially after meals)
* Nausea and vomiting
* Diarrhea
* Fever
* Yellowing of the skin and whites of the eyes (jaundice)

Causes:

* Genetics
* Obesity
* Rapid weight loss
* High cholesterol levels
* Low HDL (good) cholesterol levels
* High triglycerides
* Diabetes

Diagnosis is made through a combination of physical examination, medical history, and imaging tests such as ultrasound, CT or MRI scans. Treatment options include medication to dissolve small stones, surgery to remove the gallbladder (cholecystectomy) or laparoscopic cholecystectomy (removal of the gallbladder through small incisions).

Prevention includes maintaining a healthy weight, eating a balanced diet, and managing underlying medical conditions such as diabetes and high cholesterol. It is important to seek medical attention if symptoms persist or worsen over time.

Exocrine disorders affect the pancreas' ability to produce digestive enzymes, leading to symptoms such as abdominal pain, diarrhea, and malnutrition. The most common exocrine disorder is chronic pancreatitis, which is inflammation of the pancreas that can lead to permanent damage and scarring. Other exocrine disorders include acute pancreatitis, pancreatic insufficiency, and pancreatic cancer.

Endocrine disorders affect the pancreas' ability to produce hormones, leading to symptoms such as diabetes, hypoglycemia, and Cushing's syndrome. The most common endocrine disorder is diabetes mellitus, which is caused by a deficiency of insulin production or insulin resistance. Other endocrine disorders include hyperglycemia, hypoglycemia, and pancreatic polypeptide-secreting tumors.

Pancreatic diseases can be caused by a variety of factors, including genetics, lifestyle choices, and certain medical conditions. Treatment options for pancreatic diseases vary depending on the underlying cause and severity of the condition, and may include medications, surgery, or lifestyle changes. Early diagnosis and treatment are critical for improving outcomes in patients with pancreatic diseases.

Some of the most common types of pancreatic diseases include:

1. Diabetes mellitus: a group of metabolic disorders characterized by high blood sugar levels.
2. Chronic pancreatitis: inflammation of the pancreas that can lead to permanent damage and scarring.
3. Acute pancreatitis: sudden and severe inflammation of the pancreas, often caused by gallstones or excessive alcohol consumption.
4. Pancreatic cancer: a malignancy that can arise in the pancreas and spread to other parts of the body.
5. Pancreatic neuroendocrine tumors (PNETs): tumors that arise in the hormone-producing cells of the pancreas and can produce excessive amounts of hormones, leading to a variety of symptoms.
6. Pancreatic polypeptide-secreting tumors: rare tumors that produce excessive amounts of pancreatic polypeptide, leading to hypoglycemia and other symptoms.
7. Glucagonoma: a rare tumor that produces excessive amounts of glucagon, leading to high blood sugar levels and other symptoms.
8. Insulinoma: a rare tumor that produces excessive amounts of insulin, leading to low blood sugar levels and other symptoms.
9. Multiple endocrine neoplasia (MEN) type 1: an inherited disorder characterized by multiple endocrine tumors, including those in the pancreas.
10. Familial pancreatico-ductal adenocarcinoma (FPDA): an inherited disorder characterized by a high risk of developing pancreatic cancer.

These are just some of the possible causes of pancreatic disease, and there may be others not listed here. It is important to consult with a healthcare professional for an accurate diagnosis and appropriate treatment.

1. Infection: Bacterial or viral infections can develop after surgery, potentially leading to sepsis or organ failure.
2. Adhesions: Scar tissue can form during the healing process, which can cause bowel obstruction, chronic pain, or other complications.
3. Wound complications: Incisional hernias, wound dehiscence (separation of the wound edges), and wound infections can occur.
4. Respiratory problems: Pneumonia, respiratory failure, and atelectasis (collapsed lung) can develop after surgery, particularly in older adults or those with pre-existing respiratory conditions.
5. Cardiovascular complications: Myocardial infarction (heart attack), cardiac arrhythmias, and cardiac failure can occur after surgery, especially in high-risk patients.
6. Renal (kidney) problems: Acute kidney injury or chronic kidney disease can develop postoperatively, particularly in patients with pre-existing renal impairment.
7. Neurological complications: Stroke, seizures, and neuropraxia (nerve damage) can occur after surgery, especially in patients with pre-existing neurological conditions.
8. Pulmonary embolism: Blood clots can form in the legs or lungs after surgery, potentially causing pulmonary embolism.
9. Anesthesia-related complications: Respiratory and cardiac complications can occur during anesthesia, including respiratory and cardiac arrest.
10. delayed healing: Wound healing may be delayed or impaired after surgery, particularly in patients with pre-existing medical conditions.

It is important for patients to be aware of these potential complications and to discuss any concerns with their surgeon and healthcare team before undergoing surgery.

Learn More:

Bile Reflux | Symptoms, Causes, Treatments | American ...
https://www.gi.org/topics/bile-reflux/

The term "experimental" refers to the fact that this type of cirrhosis is typically induced in animals through the use of certain chemicals, toxins, or viruses, rather than occurring naturally in humans. The goal of studying experimental liver cirrhosis is to gain a better understanding of the underlying mechanisms and to develop new treatments for this condition.

Some examples of how experimental liver cirrhosis may be induced include:

* Administering certain chemicals or toxins, such as carbon tetrachloride or thioacetamide, to animals in order to damage the liver and trigger the formation of nodules and fibrosis.
* Infecting animals with viruses that can cause liver damage and inflammation, such as hepatitis B or C virus.
* Using genetic models to study the role of specific genes in the development of liver cirrhosis.

Experimental liver cirrhosis is often studied in laboratory animals, such as mice, rats, and pigs, using a range of techniques including histology, biochemistry, and molecular biology. The studies may focus on various aspects of the disease, such as the mechanisms of inflammation and fibrosis, the role of specific cell types or signaling pathways, and the efficacy of potential therapeutic agents.

Some examples of pathologic constrictions include:

1. Stenosis: A narrowing or constriction of a blood vessel or other tubular structure, often caused by the buildup of plaque or scar tissue.
2. Asthma: A condition characterized by inflammation and constriction of the airways, which can make breathing difficult.
3. Esophageal stricture: A narrowing of the esophagus that can cause difficulty swallowing.
4. Gastric ring constriction: A narrowing of the stomach caused by a band of tissue that forms in the upper part of the stomach.
5. Anal fissure: A tear in the lining of the anus that can cause pain and difficulty passing stools.

Pathologic constrictions can be caused by a variety of factors, including inflammation, infection, injury, or genetic disorders. They can be diagnosed through imaging tests such as X-rays, CT scans, or endoscopies, and may require surgical treatment to relieve symptoms and improve function.

Some common examples of duodenal diseases include:

1. Peptic ulcers: These are open sores that develop in the lining of the duodenum and can be caused by infection with Helicobacter pylori bacteria or the use of nonsteroidal anti-inflammatory drugs (NSAIDs).
2. Duodenal cancer: This is a rare type of cancer that develops in the lining of the duodenum. It can be treated with surgery, chemotherapy, and radiation therapy.
3. Inflammatory bowel disease (IBD): This is a chronic condition that causes inflammation in the digestive tract, including the duodenum. Symptoms of IBD include abdominal pain, diarrhea, and weight loss.
4. Duodenal webs or rings: These are congenital abnormalities that can cause blockages or narrowing in the duodenum.
5. Pancreatitis: This is inflammation of the pancreas, which can spread to the duodenum and cause damage to the lining of the duodenum.
6. Gastrointestinal hormone deficiency: This is a condition where the body does not produce enough gastrointestinal hormones, which can lead to symptoms such as diarrhea, abdominal pain, and weight loss.
7. Duodenal polyps: These are growths that develop in the lining of the duodenum and can be benign or cancerous.
8. Duodenal obstruction: This is a blockage that develops in the duodenum and can be caused by a variety of factors, including tumors, adhesions, and inflammation.

Duodenal diseases can be diagnosed through a range of tests, including:

1. Endoscopy: This is a procedure where a flexible tube with a camera and light on the end is inserted into the duodenum to visualize the inside of the duodenum and collect tissue samples.
2. Biopsy: This is a procedure where a small sample of tissue is removed from the duodenum and examined under a microscope for signs of disease.
3. CT scan or MRI: These are imaging tests that use X-rays or magnetic fields to produce detailed images of the duodenum and surrounding tissues.
4. Blood tests: These can be used to check for signs of infection, inflammation, or other conditions affecting the duodenum.
5. Stool tests: These can be used to check for signs of infection or inflammation in the duodenum.

Treatment for duodenal diseases will depend on the specific condition and its cause, but may include:

1. Medications: Such as antibiotics, anti-inflammatory drugs, and acid-suppressing medications to manage symptoms and reduce inflammation.
2. Lifestyle changes: Such as avoiding trigger foods, eating smaller meals, and managing stress.
3. Endoscopy: To remove any blockages or abnormal growths in the duodenum.
4. Surgery: In some cases, surgery may be necessary to repair damaged tissue or remove affected tissue.
5. Nutritional support: To ensure that the patient is getting enough nutrients and electrolytes.

It's important to note that a proper diagnosis from a medical professional is essential for effective treatment of duodenal diseases.

The exact cause of cholangiocarcinoma is not known, but there are several risk factors that have been linked to the development of the disease. These include:

1. Chronic inflammation of the bile ducts (cholangitis)
2. Infection with certain viruses, such as hepatitis B and C
3. Genetic conditions, such as inherited syndromes that affect the liver and bile ducts
4. Exposure to certain chemicals, such as thorium dioxide
5. Obesity and metabolic disorders

The symptoms of cholangiocarcinoma can vary depending on the location and size of the tumor. Common symptoms include:

1. Jaundice (yellowing of the skin and eyes)
2. Itching all over the body
3. Fatigue
4. Loss of appetite
5. Abdominal pain and swelling
6. Weight loss
7. Nausea and vomiting

If cholangiocarcinoma is suspected, a doctor may perform several tests to confirm the diagnosis. These may include:

1. Imaging tests, such as CT scans, MRI scans, or PET scans
2. Blood tests to check for certain liver enzymes and bilirubin levels
3. Endoscopic ultrasound to examine the bile ducts
4. Biopsy to collect a sample of tissue from the suspected tumor

Treatment for cholangiocarcinoma depends on the stage and location of the cancer, as well as the patient's overall health. Surgery is often the first line of treatment, and may involve removing the tumor and a portion of the bile ducts. In more advanced cases, chemotherapy or radiation therapy may be used to shrink the tumor before surgery or to relieve symptoms.

It's important for patients with cholangiocarcinoma to work closely with their healthcare team to develop a personalized treatment plan and to monitor their condition regularly. With prompt and appropriate treatment, some patients with cholangiocarcinoma may experience long-term survival and a good quality of life.

Symptoms of duodenal neoplasms can vary depending on the location and size of the tumor, but may include abdominal pain, weight loss, nausea, vomiting, and abdominal distension. Diagnosis is typically made through a combination of endoscopy, imaging studies such as CT scans or MRI, and biopsy. Treatment options for duodenal neoplasms depend on the type and stage of the tumor, but may include surgery, chemotherapy, and/or radiation therapy.

Duodenal Neoplasms are relatively rare, accounting for only about 1-2% of all gastrointestinal cancers. However, they can be aggressive and difficult to treat if not detected early. The prognosis for duodenal neoplasms is generally poor, with a 5-year survival rate of approximately 20-30%.

Calculi are typically classified into three types based on their composition:

1. Calcium oxalate calculi: These are the most common type of calculus and are often found in the kidneys and urinary tract. They are more likely to occur in people with a history of kidney stones or other conditions that affect calcium metabolism.
2. Magnesium ammonium phosphate calculi: These calculi are less common and typically form in the kidneys or bladder. They are often associated with chronic kidney disease or other underlying medical conditions.
3. Uric acid calculi: These calculi are rare and often form in the joints, but can also occur in the urinary tract. They are more common in people with gout or other conditions that affect uric acid metabolism.

Calculi can cause a range of symptoms depending on their size and location, including:

* Pain in the abdomen, flank, or back
* Blood in the urine (hematuria)
* Frequent urination or difficulty urinating
* Cloudy or strong-smelling urine
* Fever or chills
* Nausea and vomiting

If calculi are small and do not cause any symptoms, they may not require treatment. However, if they grow large enough to block the flow of urine or cause pain, treatment may be necessary. Treatment options for calculi include:

1. Medications: Drugs such as alpha-blockers and potassium citrate can help to dissolve calculi and reduce symptoms.
2. Shock wave lithotripsy: This is a non-invasive procedure that uses high-energy shock waves to break up calculi into smaller pieces that can be passed more easily.
3. Endoscopic surgery: A small, flexible tube with a camera and specialized tools can be inserted through the ureter or bladder to remove calculi.
4. Open surgery: In some cases, open surgery may be necessary to remove large or complex calculi.

Prevention is key in avoiding calculi. Here are some tips for preventing calculi:

1. Drink plenty of water: Adequate hydration helps to dilute uric acid and other substances in the urine, reducing the risk of calculi formation.
2. Limit alcohol intake: Alcohol can increase levels of uric acid in the blood, which can contribute to calculi formation.
3. Maintain a healthy diet: Eating a balanced diet that is low in purines and high in fruits and vegetables can help to reduce the risk of calculi.
4. Manage underlying conditions: Conditions such as gout, hyperparathyroidism, and kidney disease can increase the risk of calculi. Managing these conditions with medication and lifestyle changes can help to reduce the risk of calculi.
5. Avoid certain medications: Certain medications, such as some antibiotics and diuretics, can increase the risk of calculi formation.
6. Monitor urine output: If you have a medical condition that affects your urinary tract, such as a blockage or an obstruction, it is important to monitor your urine output to ensure that your kidneys are functioning properly.
7. Avoid prolonged bed rest: Prolonged bed rest can increase the risk of calculi formation by slowing down urine flow and allowing minerals to accumulate in the urinary tract.
8. Stay active: Regular exercise can help to improve circulation and maintain a healthy weight, which can reduce the risk of calculi formation.
9. Avoid smoking: Smoking can increase the risk of calculi formation by reducing blood flow to the kidneys and increasing the amount of oxalate in the urine.
10. Consider medications: In some cases, medications such as allopurinol or potassium citrate may be prescribed to help prevent calculi formation. These medications can help to reduce the levels of uric acid or calcium oxalate in the urine.
It is important to note that not all kidney stones are the same, and the underlying cause may vary depending on the type of stone. For example, if you have a history of gout, you may be more likely to develop uric acid stones. In this case, medications such as allopurinol or probenecid may be prescribed to help reduce the levels of uric acid in your blood and prevent calculi formation.


The condition is often caused by gallstones or other blockages that prevent the normal flow of bile from the liver to the small intestine. Over time, the scarring can lead to the formation of cirrhosis, which is characterized by the replacement of healthy liver tissue with scar tissue.

Symptoms of liver cirrhosis, biliary may include:

* Jaundice (yellowing of the skin and eyes)
* Itching
* Fatigue
* Abdominal pain
* Dark urine
* Pale stools

The diagnosis of liver cirrhosis, biliary is typically made through a combination of physical examination, medical history, and diagnostic tests such as ultrasound, CT scans, and blood tests.

Treatment for liver cirrhosis, biliary depends on the underlying cause of the condition. In some cases, surgery may be necessary to remove gallstones or repair damaged bile ducts. Medications such as antioxidants and anti-inflammatory drugs may also be prescribed to help manage symptoms and slow the progression of the disease. In severe cases, a liver transplant may be necessary.

Prognosis for liver cirrhosis, biliary is generally poor, as the condition can lead to complications such as liver failure, infection, and cancer. However, with early diagnosis and appropriate treatment, it is possible to manage the symptoms and slow the progression of the disease.

Symptoms of lithiasis may include pain in the affected area, nausea and vomiting, fever, and changes in urination patterns. Treatment for lithiasis depends on the location and size of the stone, and may involve medications to help break down the stone or surgery to remove it.

Prevention strategies for lithiasis include staying hydrated to maintain adequate fluid intake, limiting dietary oxalate intake in cases of calcium oxalate stones, and avoiding foods high in animal protein and salt in cases of uric acid stones. In some cases, medications such as allopurinol or potassium citrate may be prescribed to help prevent stone formation.

In summary, lithiasis is the formation of stones or calculi within the body, typically in the urinary tract or biliary system, and can be caused by a variety of factors. Treatment and prevention strategies vary depending on the location and type of stone, but may include medications to break down the stone or surgery to remove it.

The exact prevalence of HPS is not well-established, but it is believed to affect approximately 30% to 50% of individuals with cirrhosis. Risk factors for developing HPS include alcohol consumption, viral hepatitis, and non-alcoholic fatty liver disease (NAFLD).

The diagnosis of HPS typically involves a combination of physical examination, imaging studies such as ultrasound or CT scans, and laboratory tests to evaluate liver function. Treatment options for HPS depend on the underlying cause of the condition and may include medications to manage portal hypertension, lung fibrosis, or other complications. In severe cases, liver transplantation may be necessary.

Prognosis for individuals with HPS is generally poor, with a 5-year survival rate of approximately 50%. However, early diagnosis and appropriate management can improve outcomes and reduce the risk of complications.

Causes of Colic:

1. Gas and bloating: Gas and bloating are common causes of colic. This can occur when gas builds up in the digestive tract or when the body has difficulty processing certain types of food.
2. Constipation: Constipation can cause colic, as hard stool can put pressure on the intestines and lead to pain.
3. Diarrhea: Diarrhea can also cause colic, as loose stool can irritate the intestines and lead to pain.
4. Eating certain foods: Some foods, such as dairy or gluten, can be difficult for the body to digest and may cause colic.
5. Medical conditions: Certain medical conditions, such as IBS, GERD, or IBD, can cause colic.

Symptoms of Colic:

1. Abdominal pain or discomfort: This is the most common symptom of colic and can be described as crampy, gnawing, or sharp.
2. Gas and bloating: Patients with colic may experience gas and bloating, which can lead to discomfort and abdominal distension.
3. Diarrhea or constipation: Depending on the underlying cause of colic, patients may experience diarrhea or constipation.
4. Nausea and vomiting: Some patients with colic may experience nausea and vomiting.
5. Abdominal tenderness: The abdomen may be tender to the touch, especially in the lower right quadrant of the abdomen.

Treatment for Colic:

1. Dietary changes: Patients with colic may benefit from making dietary changes such as avoiding trigger foods, eating smaller meals, and increasing fiber intake.
2. Probiotics: Probiotics can help to regulate the gut microbiome and reduce symptoms of colic.
3. Antispasmodics: Antispasmodics, such as dicyclomine, can help to reduce abdominal pain and cramping associated with colic.
4. Simethicone: Simethicone is an antigas medication that can help to reduce bloating and discomfort associated with colic.
5. Antidepressants: Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), have been shown to be effective in reducing symptoms of colic in some patients.
6. Psychological support: Colic can be stressful and emotionally challenging for both patients and their caregivers. Psychological support and counseling may be beneficial in managing the emotional impact of colic.

It is important to note that while these treatments may help to reduce symptoms of colic, there is no cure for this condition. In most cases, colic will resolve on its own within a few months. However, if you suspect that your baby has colic, it is important to consult with your healthcare provider to rule out any other underlying medical conditions and develop an appropriate treatment plan.

Some common examples of intraoperative complications include:

1. Bleeding: Excessive bleeding during surgery can lead to hypovolemia (low blood volume), anemia (low red blood cell count), and even death.
2. Infection: Surgical wounds can become infected, leading to sepsis or bacteremia (bacterial infection of the bloodstream).
3. Nerve damage: Surgery can sometimes result in nerve damage, leading to numbness, weakness, or paralysis.
4. Organ injury: Injury to organs such as the liver, lung, or bowel can occur during surgery, leading to complications such as bleeding, infection, or organ failure.
5. Anesthesia-related complications: Problems with anesthesia can include respiratory or cardiac depression, allergic reactions, or awareness during anesthesia (a rare but potentially devastating complication).
6. Hypotension: Low blood pressure during surgery can lead to inadequate perfusion of vital organs and tissues, resulting in organ damage or death.
7. Thromboembolism: Blood clots can form during surgery and travel to other parts of the body, causing complications such as stroke, pulmonary embolism, or deep vein thrombosis.
8. Postoperative respiratory failure: Respiratory complications can occur after surgery, leading to respiratory failure, pneumonia, or acute respiratory distress syndrome (ARDS).
9. Wound dehiscence: The incision site can separate or come open after surgery, leading to infection, fluid accumulation, or hernia.
10. Seroma: A collection of serous fluid that can develop at the surgical site, which can become infected and cause complications.
11. Nerve damage: Injury to nerves during surgery can result in numbness, weakness, or paralysis, sometimes permanently.
12. Urinary retention or incontinence: Surgery can damage the bladder or urinary sphincter, leading to urinary retention or incontinence.
13. Hematoma: A collection of blood that can develop at the surgical site, which can become infected and cause complications.
14. Pneumonia: Inflammation of the lungs after surgery can be caused by bacteria, viruses, or fungi and can lead to serious complications.
15. Sepsis: A systemic inflammatory response to infection that can occur after surgery, leading to organ dysfunction and death if not treated promptly.

It is important to note that these are potential complications, and not all patients will experience them. Additionally, many of these complications are rare, and the vast majority of surgeries are successful with minimal or no complications. However, it is important for patients to be aware of the potential risks before undergoing surgery so they can make an informed decision about their care.

A persistent inflammation of the pancreas that can last for months or even years, leading to chronic pain, digestive problems, and other complications.

Pancreatitis is a condition where the pancreas becomes inflamed, which can be caused by various factors such as gallstones, alcohol consumption, certain medications, and genetics. Chronic pancreatitis is a type of pancreatitis that persists over time, leading to ongoing symptoms and complications.

The symptoms of chronic pancreatitis can vary but may include abdominal pain, nausea, vomiting, diarrhea, weight loss, and fatigue. The condition can also lead to complications such as infection, bleeding, and narrowing or blockage of the pancreatic ducts.

Chronic pancreatitis is diagnosed through a combination of medical history, physical examination, laboratory tests, and imaging studies. Treatment options for chronic pancreatitis may include medications to manage pain and inflammation, lifestyle changes such as avoiding alcohol and fatty foods, and in some cases, surgery to remove the damaged pancreatic tissue.

The prognosis for chronic pancreatitis varies depending on the underlying cause of the condition and the severity of the inflammation. In some cases, the condition can be managed with medication and lifestyle changes, while in others, surgery may be necessary to remove the damaged pancreatic tissue.

Preventing chronic pancreatitis is not always possible, but avoiding risk factors such as alcohol consumption and certain medications can help reduce the likelihood of developing the condition. Early diagnosis and treatment can also improve outcomes for individuals with chronic pancreatitis.

Examples of 'Diverticulum' in sentence:

1. The patient was diagnosed with a diverticulum in her colon, which was causing abdominal pain and changes in bowel habits.
2. The doctor recommended that the patient avoid fatty foods and drink plenty of fluids to help manage her diverticulum.
3. The diverticulum was successfully treated with antibiotics, but the patient had to make some lifestyle changes to prevent future complications.

Villous adenomas are characterized by a villous surface, which is covered with finger-like projections called villi. These villi have a large surface area, allowing for increased absorption of nutrients and secretion of hormones and other substances.

Villous adenomas are typically less than 1 cm in size and are often found incidentally during diagnostic procedures such as colonoscopy or barium enema. They are usually asymptomatic, but may cause bleeding or obstruction if they become large enough.

The risk of malignant transformation for villous adenomas is low, ranging from 0-15%. However, the presence of multiple villous adenomas, a larger size, and certain histological features such as dysplasia or an irregular border may increase the risk of malignancy.

Treatment of villous adenomas usually involves polypectomy, which is the removal of the polyp using endoscopy or surgery. Follow-up colonoscopies are often recommended to monitor for any recurrences or new polyps. In some cases, patients with multiple or large villous adenomas may be considered for prophylactic colectomy, which is the preventive removal of the colon to reduce the risk of colorectal cancer.

In summary, villous adenomas are precancerous growths in the colon that have a low risk of malignant transformation but can cause bleeding or obstruction if left untreated. They are typically found incidentally during diagnostic procedures and are treated with polypectomy or prophylactic colectomy.

There are several types of PCS, including:

1. Bouveret's syndrome: This is a severe form of PCS that occurs within the first few days after cholecystectomy, characterized by intense abdominal pain, fever, and distension of the small intestine.
2. Mirizzi's syndrome: This type of PCS develops when the cystic duct remnant is obstructed, causing bile to accumulate in the gallbladder bed and leak into surrounding tissues, leading to inflammation and infection.
3. Acute pancreatitis: This condition occurs when the pancreatic duct becomes blocked or obstructed, causing pancreatic enzymes to build up and cause inflammation in the pancreas and surrounding tissues.
4. Chronic pancreatitis: This is a long-term form of PCS that can develop after cholecystectomy, characterized by persistent inflammation and damage to the pancreas, leading to abdominal pain, diarrhea, and weight loss.
5. Biliary-pancreatic dyskinesia: This is a chronic form of PCS that occurs when the sphincter of Oddi, which regulates the flow of bile and pancreatic juice into the small intestine, becomes dysfunctional, leading to abdominal pain, diarrhea, and malabsorption.

The symptoms of PCS can be severe and debilitating, affecting quality of life and requiring ongoing medical management. Treatment options for PCS include medications to manage symptoms, endoscopic therapy to clear obstructions, and in some cases, further surgical intervention.

It is essential to seek medical attention if you experience persistent or severe abdominal pain, as early diagnosis and treatment can help alleviate symptoms and prevent complications. A healthcare professional will perform a thorough physical examination and order imaging tests such as CT scans or endoscopy to confirm the diagnosis of PCS. Treatment will depend on the underlying cause of the condition, but may include medications to manage pain, inflammation, and infection, as well as lifestyle modifications to ensure proper digestion and nutrition.

The term "papillary" refers to the fact that the cancer cells grow in a finger-like shape, with each cell forming a small papilla (bump) on the surface of the tumor. APC is often slow-growing and may not cause any symptoms in its early stages.

APC is generally considered to be less aggressive than other types of cancer, such as ductal carcinoma in situ (DCIS) or invasive breast cancer. However, it can still spread to other parts of the body if left untreated. Treatment options for APC may include surgery, radiation therapy, and/or hormone therapy, depending on the location and stage of the cancer.

It's worth noting that APC is sometimes referred to as "papillary adenocarcinoma" or simply "papillary cancer." However, these terms are often used interchangeably with "adenocarcinoma, papillary" in medical literature and clinical practice.

Symptoms of fascioliasis can vary depending on the severity of the infection and may include:

1. Abdominal pain
2. Diarrhea
3. Vomiting
4. Fatigue
5. Weight loss
6. Anemia
7. Elevated liver enzymes
8. Inflammation of the liver, bile ducts, or pancreas

If left untreated, fascioliasis can lead to serious complications such as:

1. Cholangiohepatitis (inflammation of the bile ducts and liver)
2. Hepatic cysts or cirrhosis (scarring of the liver)
3. Biliary obstruction or pancreatitis (inflammation of the pancreas)

Diagnosis of fascioliasis typically involves a combination of physical examination, medical history, and laboratory tests such as:

1. Blood tests to detect antibodies against the parasite
2. Detection of the parasite in stool or bile samples
3. Imaging studies such as ultrasound or CT scans to visualize the liver and bile ducts

Treatment of fascioliasis usually involves the use of antiparasitic drugs, such as triclabendazole or nitazoxanide, to eliminate the parasite from the body. Supportive care may also be provided to manage symptoms and prevent complications.

Prevention of fascioliasis primarily involves measures to avoid ingesting contaminated food or water, such as:

1. Avoiding consumption of raw or undercooked meat, particularly pork or lamb
2. Properly cooking and storing food
3. Avoiding consumption of untreated water
4. Using proper sanitation and hygiene practices
5. Avoiding contact with contaminated soil or water

In areas where fascioliasis is common, it is important to be aware of the risk and take appropriate precautions to prevent infection. Early detection and treatment can help prevent complications and improve outcomes for patients with fascioliasis.

There are many different types of liver diseases, including:

1. Alcoholic liver disease (ALD): A condition caused by excessive alcohol consumption that can lead to inflammation, scarring, and cirrhosis.
2. Viral hepatitis: Hepatitis A, B, and C are viral infections that can cause inflammation and damage to the liver.
3. Non-alcoholic fatty liver disease (NAFLD): A condition where there is an accumulation of fat in the liver, which can lead to inflammation and scarring.
4. Cirrhosis: A condition where the liver becomes scarred and cannot function properly.
5. Hemochromatosis: A genetic disorder that causes the body to absorb too much iron, which can damage the liver and other organs.
6. Wilson's disease: A rare genetic disorder that causes copper to accumulate in the liver and brain, leading to damage and scarring.
7. Liver cancer (hepatocellular carcinoma): Cancer that develops in the liver, often as a result of cirrhosis or viral hepatitis.

Symptoms of liver disease can include fatigue, loss of appetite, nausea, abdominal pain, dark urine, pale stools, and swelling in the legs. Treatment options for liver disease depend on the underlying cause and may include lifestyle changes, medication, or surgery. In severe cases, a liver transplant may be necessary.

Prevention of liver disease includes maintaining a healthy diet and lifestyle, avoiding excessive alcohol consumption, getting vaccinated against hepatitis A and B, and managing underlying medical conditions such as obesity and diabetes. Early detection and treatment of liver disease can help to prevent long-term damage and improve outcomes for patients.

The exact cause of sclerosing cholangitis is not known, but it is believed to be an autoimmune condition, meaning that the body's immune system mistakenly attacks healthy bile duct cells, leading to inflammation and scarring.

Symptoms of sclerosing cholangitis can include:

* Jaundice (yellowing of the skin and eyes)
* Itching all over the body
* Fatigue
* Loss of appetite
* Nausea and vomiting
* Abdominal pain
* Weight loss

If sclerosing cholangitis is not treated, it can lead to complications such as:

* Bile duct cancer
* Intestinal obstruction
* Sepsis (a potentially life-threatening infection of the bloodstream)

Treatment for sclerosing cholangitis typically involves a combination of medications and surgery. Medications used to treat the condition include:

* Ursodeoxycholic acid (UDCA), which helps to dissolve bile stones and reduce inflammation
* Antibiotics, which help to prevent or treat infections
* Immunosuppressive drugs, which help to suppress the immune system and prevent further damage to the bile ducts

Surgery may be necessary to remove damaged or blocked bile ducts. In some cases, a liver transplant may be required if the condition is severe and there is significant liver damage.

1. Adverse drug reactions (ADRs): These are side effects caused by medications, such as allergic reactions, liver damage, or other systemic problems. ADRs can be a significant cause of iatrogenic disease and can result from taking the wrong medication, taking too much medication, or taking medication for too long.
2. Infections acquired during medical procedures: Patients who undergo invasive medical procedures, such as surgeries or insertion of catheters, are at risk of developing infections. These infections can be caused by bacteria, viruses, or other microorganisms that enter the body through the surgical site or the catheter.
3. Surgical complications: Complications from surgery can range from minor issues, such as bruising and swelling, to more serious problems, such as infection, organ damage, or nerve injury. These complications can be caused by errors during the procedure, poor post-operative care, or other factors.
4. Medication overuse or underuse: Medications that are prescribed inappropriately or in excess can cause iatrogenic disease. For example, taking too much medication can lead to adverse drug reactions, while taking too little medication may not effectively treat the underlying condition.
5. Medical imaging complications: Medical imaging procedures, such as X-rays and CT scans, can sometimes cause iatrogenic disease. For example, excessive radiation exposure from these procedures can increase the risk of cancer.
6. Psychiatric iatrogenesis: This refers to harm caused by psychiatric treatment, such as medication side effects or inappropriate use of electroconvulsive therapy (ECT).
7. Overdiagnosis: Overdiagnosis occurs when a condition is diagnosed that would not have caused symptoms or required treatment during the person's lifetime. This can lead to unnecessary testing, treatment, and other iatrogenic harms.
8. Unnecessary surgery: Surgical procedures that are not necessary can cause harm and increase healthcare costs.
9. Inappropriate referrals: Referring patients for unnecessary tests or procedures can lead to iatrogenic disease and increased healthcare costs.
10. Healthcare provider burnout: Burnout among healthcare providers can lead to errors, adverse events, and other forms of iatrogenic disease.

It is important to note that these are just a few examples of iatrogenic disease, and there may be other factors that contribute to this phenomenon as well. Additionally, while many of the factors listed above are unintentional, some may be due to negligence or other forms of misconduct. In all cases, it is important for healthcare providers to take steps to prevent iatrogenic disease and promote high-quality, patient-centered care.

Pancreatic adenocarcinoma is the most common type of malignant pancreatic neoplasm and accounts for approximately 85% of all pancreatic cancers. It originates in the glandular tissue of the pancreas and has a poor prognosis, with a five-year survival rate of less than 10%.

Pancreatic neuroendocrine tumors (PNETs) are less common but more treatable than pancreatic adenocarcinoma. These tumors originate in the hormone-producing cells of the pancreas and can produce excess hormones that cause a variety of symptoms, such as diabetes or high blood sugar. PNETs are classified into two main types: functional and non-functional. Functional PNETs produce excess hormones and are more aggressive than non-functional tumors.

Other rare types of pancreatic neoplasms include acinar cell carcinoma, ampullary cancer, and oncocytic pancreatic neuroendocrine tumors. These tumors are less common than pancreatic adenocarcinoma and PNETs but can be equally aggressive and difficult to treat.

The symptoms of pancreatic neoplasms vary depending on the type and location of the tumor, but they often include abdominal pain, weight loss, jaundice, and fatigue. Diagnosis is typically made through a combination of imaging tests such as CT scans, endoscopic ultrasound, and biopsy. Treatment options for pancreatic neoplasms depend on the type and stage of the tumor but may include surgery, chemotherapy, radiation therapy, or a combination of these.

Prognosis for patients with pancreatic neoplasms is generally poor, especially for those with advanced stages of disease. However, early detection and treatment can improve survival rates. Research into the causes and mechanisms of pancreatic neoplasms is ongoing, with a focus on developing new and more effective treatments for these devastating diseases.




Carcinoid tumors are usually found in the appendix, small intestine, rectum, or other parts of the gastrointestinal tract. They can also occur in the lungs, pancreas, or other organs. These tumors tend to grow slowly and often do not cause any symptoms until they have grown quite large.

Carcinoid tumors are diagnosed through a combination of imaging tests such as CT scans, MRI scans, and endoscopies, along with a biopsy to confirm the presence of cancer cells. Treatment for carcinoid tumors depends on the location, size, and stage of the tumor, as well as the patient's overall health. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these.

Some of the symptoms that may be associated with carcinoid tumors include:

* Flushing (redness and warmth of the skin)
* Wheezing
* Shortness of breath
* Abdominal pain
* Diarrhea
* Weight loss

Carcinoid tumors are relatively rare, accounting for only about 1% to 5% of all cancer cases. However, they tend to be more common in certain parts of the world, such as North America and Europe. The exact cause of carcinoid tumors is not known, but they are thought to be linked to genetic mutations that occur during fetal development.

Overall, while carcinoid tumors are rare and can be challenging to diagnose and treat, advances in medical technology and cancer research have improved the outlook for patients with these types of tumors. With early detection and appropriate treatment, many people with carcinoid tumors can achieve long-term survival and a good quality of life.

Treatment options for duodenal obstruction depend on the underlying cause of the condition. Surgery may be required to remove any blockages or scar tissue that is causing the obstruction. In some cases, a stent may be placed in the duodenum to help keep it open. Medications such as proton pump inhibitors and anti-inflammatory drugs may also be used to manage symptoms.

Early diagnosis and treatment of duodenal obstruction are important to prevent complications such as malnutrition, dehydration, and potentially life-threatening infections. It is essential for individuals with suspected duodenal obstruction to seek medical attention promptly if they experience any symptoms.

What is the medical definition of 'Duodenal Obstruction'?

Duodenal obstruction is defined as a blockage or narrowing of the duodenum, which is the first part of the small intestine.

1. Gallstones: Gallstones can block the flow of bile from the liver to the small intestine, causing bile to back up into the bloodstream and leading to hemobilia.
2. Pancreatitis: Inflammation of the pancreas (pancreatitis) can cause bleeding in the bile ducts, leading to hemobilia.
3. Cancer: Bile duct cancer or other types of cancer that have spread to the bile ducts can cause hemobilia.
4. Trauma: Injury to the bile ducts, such as from a car accident or fall, can cause bleeding and lead to hemobilia.
5. Vasculitis: Inflammation of the blood vessels (vasculitis) can cause bleeding in the bile ducts and lead to hemobilia.

Hemobilia is a potentially life-threatening condition that requires prompt medical attention, especially if it is caused by a serious underlying condition such as gallstones or cancer. Treatment options for hemobilia will depend on the underlying cause and may include surgery, medication, or endoscopy.

There are many different types of cysts that can occur in the body, including:

1. Sebaceous cysts: These are small, usually painless cysts that form in the skin, particularly on the face, neck, or torso. They are filled with a thick, cheesy material and can become inflamed or infected.
2. Ovarian cysts: These are fluid-filled sacs that form on the ovaries. They are common in women of childbearing age and can cause pelvic pain, bloating, and other symptoms.
3. Kidney cysts: These are fluid-filled sacs that form in the kidneys. They are usually benign but can cause problems if they become large or infected.
4. Dermoid cysts: These are small, usually painless cysts that form in the skin or organs. They are filled with skin cells, hair follicles, and other tissue and can become inflamed or infected.
5. Pilar cysts: These are small, usually painless cysts that form on the scalp. They are filled with a thick, cheesy material and can become inflamed or infected.
6. Epidermoid cysts: These are small, usually painless cysts that form just under the skin. They are filled with a thick, cheesy material and can become inflamed or infected.
7. Mucous cysts: These are small, usually painless cysts that form on the fingers or toes. They are filled with a clear, sticky fluid and can become inflamed or infected.
8. Baker's cyst: This is a fluid-filled cyst that forms behind the knee. It can cause swelling and pain in the knee and is more common in women than men.
9. Tarlov cysts: These are small, fluid-filled cysts that form in the spine. They can cause back pain and other symptoms, such as sciatica.
10. ganglion cysts: These are noncancerous lumps that form on the joints or tendons. They are filled with a thick, clear fluid and can cause pain, swelling, and limited mobility.

It's important to note that this is not an exhaustive list and there may be other types of cysts that are not included here. If you suspect that you have a cyst, it's always best to consult with a healthcare professional for proper diagnosis and treatment.

Pseudocysts are typically caused by inflammation or injury to the pancreas, which can lead to the formation of fluid-filled spaces within the organ. These spaces are not surrounded by a layer of epithelial cells, as is the case with true pancreatic cysts.

Pancreatic pseudocysts may not cause any symptoms and may be discovered incidentally during diagnostic imaging studies. However, they can also cause abdominal pain, nausea, vomiting, fever, and other symptoms depending on their size and location.

Treatment of pancreatic pseudocysts is usually conservative, involving observation, fluid drainage, and management of any underlying causes such as infection or inflammation. Surgical intervention may be necessary if the pseudocyst becomes infected, bleeds, or causes other complications.

It's important to note that while pancreatic pseudocysts are generally less serious than true cysts, they can still cause significant morbidity and mortality if left untreated or if there is a delay in diagnosis and treatment. Therefore, it's important for healthcare providers to be aware of the differences between pseudocysts and true pancreatic cysts, as well as the appropriate diagnostic and treatment approaches for each condition.

Foreign-body migration refers to the movement or migration of a foreign object or material within the body over time. This can occur after a surgical procedure, injury, or other medical intervention where a foreign object is introduced into the body. The term "foreign body" includes any object or material that is not naturally present within the body, such as implants, sutures, staples, and other medical devices.

The migration of a foreign body can occur due to various factors, including:

1. Mechanical forces: Movement of the body, such as during exercise or daily activities, can cause the foreign object to shift position or migrate to another part of the body.
2. Biological forces: The body's natural healing processes and inflammatory responses can cause the foreign object to move or change shape over time.
3. Chemical forces: Corrosion or degradation of the foreign material can lead to its migration within the body.
4. Cellular forces: Cells in the body can surround and interact with the foreign object, leading to its movement or displacement.

The migration of a foreign body can have significant clinical implications, including:

1. Pain and discomfort: The movement of a foreign object within the body can cause pain, discomfort, and inflammation.
2. Infection: The migration of a foreign object can increase the risk of infection, particularly if the object is made of a material that is susceptible to bacterial growth.
3. Organ damage: If the migrated foreign object damages surrounding tissues or organs, it can lead to serious complications and long-term health problems.
4. Revision surgery: In some cases, the migration of a foreign body may require revision surgery to remove or reposition the object.

To prevent foreign-body migration, medical professionals use various techniques, such as:

1. Implant fixation: Implants can be fixed in place using bone screws, sutures, or other fixation devices to minimize their movement.
2. Biocompatible materials: Using biocompatible materials for implants and other medical devices can reduce the risk of foreign-body reaction and migration.
3. Proper surgical technique: Surgeons must use proper surgical techniques when inserting foreign objects into the body, such as using a sterile environment and appropriate insertion angles.
4. Postoperative care: Proper postoperative care, including antibiotics and pain management, can help prevent complications and promote healing.

Overall, preventing the migration of foreign bodies is essential to ensure successful medical outcomes and minimize the risk of complications.

Types: There are several types of digestive system fistulae, including:

* Esophago-gastric fistula: A connection between the esophagus and stomach
* Gastric-duodenal fistula: A connection between the stomach and small intestine
* Jejuno-ileal fistula: A connection between the small intestine and large intestine
* Ileo-caecal fistula: A connection between the large intestine and the caecum, a pouch-like structure in the appendix

Causes: Digestive system fistulae can be caused by a variety of factors, including:

* Inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis
* Diverticulitis, a condition in which pouches form in the wall of the GI tract and become infected
* Cancer, such as rectal cancer or colon cancer
* Radiation therapy to the pelvic area
* Infections, such as abscesses or gangrene

Symptoms: Symptoms of digestive system fistulae can include:

* Pain in the abdomen or pelvis
* Swelling in the abdomen or pelvis
* Fever
* Diarrhea or constipation
* Abdominal distension
* Weight loss

Treatment: Treatment for digestive system fistulae depends on the underlying cause and may include antibiotics, surgery, or other interventions. In some cases, the condition may be managed with draining of the abscess or fistula, or with the use of a nasogastric tube to drain the contents of the stomach. Surgical repair of the fistula may also be necessary.

Prognosis: The prognosis for digestive system fistulae depends on the underlying cause and the severity of the condition. In general, early diagnosis and treatment can improve outcomes. However, if left untreated, the condition can lead to serious complications such as sepsis, organ damage, or death.

Prevention: Preventing digestive system fistulae involves managing any underlying conditions that may contribute to their development. For example, people with inflammatory bowel disease should adhere to their treatment regimens and make lifestyle changes as recommended by their healthcare providers. In addition, good hand hygiene and proper sterilization techniques can help prevent the spread of infections that can lead to fistulae.

Examples of mixed tumors, malignant include:

1. Melanoma-squamous cell carcinoma: This type of skin cancer is a mix of melanocytes (the cells that produce pigment) and squamous cells (thin, flat cells that make up the outer layer of skin).
2. Adenoid cystic carcinoma with squamous differentiation: This type of head and neck cancer has features of both adenoid cystic carcinoma (a type of salivary gland cancer) and squamous cell carcinoma.
3. Uterine leiomyosarcoma with endometrial adenocarcinoma: This type of uterine cancer is a mix of leiomyosarcoma (a type of smooth muscle cancer) and endometrial adenocarcinoma (a type of glandular cancer).
4. Metanephric stromal tumor with oncocytic changes: This type of kidney cancer is a mix of metanephric stromal tumor (a type of connective tissue cancer) and oncocytic changes (abnormal cells that resemble normal cells but have lost their ability to regulate growth).
5. Synovial sarcoma with osteoclast-like giant cells: This type of soft tissue cancer is a mix of synovial sarcoma (a type of connective tissue cancer) and osteoclast-like giant cells (large cells that resemble bone-forming cells).

Treatment for mixed tumors, malignant can vary depending on the specific types of cancer present and the extent of the disease. Surgery, radiation therapy, and chemotherapy may be used alone or in combination to treat the tumor. In some cases, a clinical trial may be an option.

Mixed tumors, malignant are often more aggressive and difficult to treat than single-type tumors because they contain multiple types of cancer cells that can grow and spread differently. However, advances in cancer diagnosis and treatment have improved the outlook for some patients with mixed tumors. The prognosis and treatment options for mixed tumors depend on the specific types of cancer present, the stage of the disease, and other individual factors.

A patient's age, overall health, and the presence of any other medical conditions can also affect their prognosis and treatment options. If you or a loved one has been diagnosed with a mixed tumor, it is essential to discuss your treatment options with a qualified healthcare professional who specializes in cancer care. They can help you understand the specific types of cancer present, the stage of the disease, and the most appropriate treatment plan for your individual situation.

In some cases, a clinical trial may be an option. Clinical trials are research studies that evaluate new treatments or combinations of treatments to see if they are safe and effective. Participating in a clinical trial may give you access to innovative therapies that are not yet widely available. However, it is essential to discuss the potential risks and benefits of clinical trials with your healthcare professional before making a decision.

In summary, mixed tumors are complex cancer diagnoses that can be challenging to treat. However, advances in cancer diagnosis and treatment have improved the outlook for some patients. If you or a loved one has been diagnosed with a mixed tumor, it is essential to discuss your treatment options with a qualified healthcare professional who specializes in cancer care. They can help you understand the specific types of cancer present, the stage of the disease, and the most appropriate treatment plan for your individual situation.

In some cases, a clinical trial may be an option. Clinical trials are research studies that evaluate new treatments or combinations of treatments to see if they are safe and effective. Participating in a clinical trial may give you access to innovative therapies that are not yet widely available. However, it is essential to discuss the potential risks and benefits of clinical trials with your healthcare professional before making a decision.

Examples of acute diseases include:

1. Common cold and flu
2. Pneumonia and bronchitis
3. Appendicitis and other abdominal emergencies
4. Heart attacks and strokes
5. Asthma attacks and allergic reactions
6. Skin infections and cellulitis
7. Urinary tract infections
8. Sinusitis and meningitis
9. Gastroenteritis and food poisoning
10. Sprains, strains, and fractures.

Acute diseases can be treated effectively with antibiotics, medications, or other therapies. However, if left untreated, they can lead to chronic conditions or complications that may require long-term care. Therefore, it is important to seek medical attention promptly if symptoms persist or worsen over time.

The condition can be caused by a variety of factors, including excessive alcohol consumption, viral hepatitis, non-alcoholic fatty liver disease, and certain medications. It can also be a complication of other diseases such as hemochromatosis and Wilson's disease.

The symptoms of liver cirrhosis can vary depending on the severity of the disease, but may include fatigue, loss of appetite, nausea, abdominal swelling, and pain in the upper right side of the abdomen. As the disease progresses, it can lead to complications such as esophageal varices, ascites, and liver failure, which can be life-threatening.

There is no cure for liver cirrhosis, but treatment options are available to manage the symptoms and slow the progression of the disease. These may include medications to control swelling and pain, dietary changes, and in severe cases, liver transplantation. In some cases, a liver transplant may be necessary if the disease has caused significant damage and there is no other option to save the patient's life.

In conclusion, liver cirrhosis is a serious and potentially life-threatening condition that can cause significant damage to the liver and lead to complications such as liver failure. It is important for individuals to be aware of the risk factors and symptoms of the disease in order to seek medical attention if they suspect they may have liver cirrhosis. With proper treatment and management, it is possible to slow the progression of the disease and improve the patient's quality of life.

The digestive system neoplasms are a group of abnormal growths or tumors that occur in the organs and tissues of the gastrointestinal (GI) tract. These neoplasms can be benign or malignant, and their impact on the body can range from minimal to life-threatening.

Types:

There are several types of digestive system neoplasms, including:

1. Colorectal cancer: A malignant tumor that develops in the colon or rectum.
2. Gastric cancer: A malignant tumor that develops in the stomach.
3. Pancreatic cancer: A malignant tumor that develops in the pancreas.
4. Small intestine cancer: A rare type of cancer that develops in the small intestine.
5. Esophageal cancer: A malignant tumor that develops in the esophagus.
6. Liver cancer (hepatocellular carcinoma): A malignant tumor that develops in the liver.
7. Anal canal cancer: A rare type of cancer that develops in the anus.
8. Gallbladder cancer: A rare type of cancer that develops in the gallbladder.

Causes and risk factors:

The exact cause of digestive system neoplasms is not always known, but certain risk factors can increase the likelihood of developing these conditions. These include:

1. Age: The risk of developing digestive system neoplasms increases with age.
2. Family history: Having a family history of these conditions can increase the risk.
3. Inflammatory bowel disease: People with inflammatory bowel disease, such as ulcerative colitis or Crohn's disease, are at higher risk of developing colorectal cancer.
4. Diets high in fat and low in fiber: A diet high in fat and low in fiber may increase the risk of developing colon cancer.
5. Smoking: Smoking can increase the risk of developing several types of digestive system neoplasms, including colorectal cancer and pancreatic cancer.
6. Alcohol consumption: Heavy alcohol consumption may increase the risk of developing liver cancer.
7. Obesity: Being overweight or obese may increase the risk of developing several types of digestive system neoplasms, including colorectal cancer and pancreatic cancer.
8. Infection with certain viruses: Some viruses, such as human papillomavirus (HPV) and hepatitis B and C, can increase the risk of developing certain types of digestive system neoplasms.

Symptoms and diagnosis:

The symptoms of digestive system neoplasms vary depending on the location and size of the tumor. Some common symptoms include:

1. Blood in the stool or vomit
2. Abdominal pain or discomfort
3. Weight loss
4. Fatigue
5. Loss of appetite
6. Jaundice (yellowing of the skin and eyes)

If a patient experiences any of these symptoms, they should see a healthcare provider for further evaluation. A diagnosis of digestive system neoplasms is typically made through a combination of imaging tests such as CT scans, MRI scans, endoscopy, and biopsy. Treatment options:

The treatment of digestive system neoplasms depends on the type, size, location, and stage of the tumor. Some common treatment options include:

1. Surgery: Surgery is often the first line of treatment for many types of digestive system neoplasms. The goal of surgery is to remove the tumor and any affected tissue.
2. Chemotherapy: Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. It may be used before or after surgery, or as a palliative therapy to relieve symptoms.
3. Radiation therapy: Radiation therapy uses high-energy rays to kill cancer cells. It may be used alone or in combination with other treatments.
4. Targeted therapy: Targeted therapy is a type of cancer treatment that targets specific molecules involved in the growth and spread of cancer cells. Examples of targeted therapies used to treat digestive system neoplasms include bevacizumab, which targets vascular endothelial growth factor (VEGF) and aflibercept, which targets vascular endothelial growth factor receptor 2 (VEGFR2).
5. Immunotherapy: Immunotherapy is a type of cancer treatment that uses the body's immune system to fight cancer cells. Examples of immunotherapies used to treat digestive system neoplasms include pembrolizumab, which targets programmed death-1 (PD-1) and nivolumab, which targets PD-1 and CTLA-4.
6. Stenting or embolization: These procedures involve placing a small tube or particles into the blood vessels to block the flow of blood to the tumor, which can cause it to shrink or stop growing.
7. Palliative care: Palliative care is a type of treatment that focuses on relieving symptoms and improving quality of life for people with advanced cancer. It may include medications, radiation therapy, or other interventions to manage pain, bleeding, or other complications.
8. Clinical trials: These are research studies that involve testing new treatments or combinations of treatments to see if they are effective and safe. Participating in a clinical trial may give patients access to innovative therapies that are not yet widely available.

It's important to note that the specific treatment plan for digestive system neoplasms will depend on the type, location, size, and stage of the cancer, as well as other individual factors such as the patient's age, overall health, and preferences. Patients should discuss their treatment options with their healthcare provider to determine the best course of action for their specific situation.

Multiple primary neoplasms can arise in different organs or tissues throughout the body, such as the breast, colon, prostate, lung, or skin. Each tumor is considered a separate entity, with its own unique characteristics, including size, location, and aggressiveness. Treatment for multiple primary neoplasms typically involves surgery, chemotherapy, radiation therapy, or a combination of these modalities.

The diagnosis of multiple primary neoplasms can be challenging due to the overlapping symptoms and radiological findings between the different tumors. Therefore, it is essential to have a thorough clinical evaluation and diagnostic workup to rule out other possible causes of the symptoms and confirm the presence of multiple primary neoplasms.

Multiple primary neoplasms are more common than previously thought, with an estimated prevalence of 2% to 5% in some populations. The prognosis for patients with multiple primary neoplasms varies depending on the location, size, and aggressiveness of each tumor, as well as the patient's overall health status.

It is important to note that multiple primary neoplasms are not the same as metastatic cancer, in which a single primary tumor spreads to other parts of the body. Multiple primary neoplasms are distinct tumors that arise independently from different primary sites within the body.

The severity and impact of pancreatic fistula can vary depending on factors such as the size and location of the fistula, the extent of the pancreatectomy, and the overall health status of the individual. Treatment options for pancreatic fistula may include conservative management with supportive care, surgical repair or revision of the pancreatectomy, or other interventional procedures to manage symptoms and prevent complications.

The exact cause of Biliary Atresia is unknown, but it is thought to be related to genetic mutations or environmental factors during fetal development. Symptoms include jaundice (yellowing of the skin and eyes), poor feeding, and a large liver size. If left untreated, Biliary Atresia can lead to long-term complications such as liver cirrhosis, liver failure, and an increased risk of liver cancer.

Treatment for Biliary Atresia usually involves a surgical procedure called the Kasai procedure, where the damaged bile ducts are removed and replaced with a section of the small intestine. In some cases, a liver transplant may be necessary if the disease is advanced or if there are complications such as liver cirrhosis.

Overall, Biliary Atresia is a rare and complex condition that requires early diagnosis and treatment to prevent long-term complications and improve outcomes for affected individuals.

Note: Portal hypertension is a common complication of liver disease, especially cirrhosis. It is characterized by elevated pressure within the portal vein system, which can lead to splanchnic vasodilation, increased blood flow, and edema in the splanchnic organ.

Symptoms: Symptoms of portal hypertension may include ascites (fluid accumulation in the abdomen), encephalopathy (mental confusion or disorientation), gastrointestinal bleeding, and jaundice (yellowing of the skin and eyes).

Diagnosis: The diagnosis of portal hypertension is based on a combination of clinical findings, laboratory tests, and imaging studies. Laboratory tests may include liver function tests, blood counts, and coagulation studies. Imaging studies may include ultrasonography, computed tomography (CT), or magnetic resonance imaging (MRI).

Treatment: Treatment of portal hypertension depends on the underlying cause and may include medications to control symptoms, such as beta blockers to reduce portal pressure, antibiotics to treat infection, and nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain. In severe cases, surgery or shunt procedures may be necessary.

Prognosis: The prognosis for patients with portal hypertension is generally poor, as it is often associated with advanced liver disease. The 5-year survival rate for patients with cirrhosis and portal hypertension is approximately 50%.

This conduction of bile is the main function of the common bile duct. The hormone cholecystokinin, when stimulated by a fatty ... The common bile duct, sometimes abbreviated as CBD, is a duct in the gastrointestinal tract of organisms that have a ... It is formed by the confluence of the common hepatic duct and cystic duct and terminates by uniting with pancreatic duct, ... Obstruction of the common bile duct and related jaundice has been documented since at least since the time of Erasistratus. The ...
The common bile duct and pancreatic duct appear to be unobstructed. Treatment is removal of the gallstone from the bile duct ... Common bile duct stone, also known as choledocholithiasis, is the presence of gallstones in the common bile duct (CBD) (thus ... "Open or Laparoscopic Common Bile Duct Exploration (Choledocholithotomy)". The New York Times Health Guide. The New York Times ... While stones can frequently pass through the common bile duct into the duodenum, some stones may be too large to pass through ...
Cuschieri, A.; Berci, G. (1984). Common Bile Duct Exploration. Boston: Martinus Nijhoff. Berci, G.; Cuschieri, A. (1986). ... Berci, G.; Cuschieri, A. (1996). Bile Ducts and Bile Duct Stones. Philadelphia: Saunders. "Professor Sir Alfred Cuschieri". IBC ...
Oh L. "Common bile duct , Radiology Reference Article , Radiopaedia.org". Radiopaedia. Retrieved 2020-04-22. Scott-Conner CE, ... Anastomotic stricture can lead to cholangitis, or inflammation of the bile duct. Narrowing of the bile duct leads to a buildup ... An incision should be made in the hepatoduodenal ligament for the surgeon to visualise the common bile duct. An incision of ... "Common Bile Duct Function, Anatomy & Definition , Body Maps". Healthline. 29 October 2014. Retrieved 2020-04-22. " ...
... interlobular bile ducts → intrahepatic bile ducts → left and right hepatic ducts merge to form → common hepatic duct exits ... The top half of the common bile duct is associated with the liver, while the bottom half of the common bile duct is associated ... It joins the cystic duct (carrying bile to and from the gallbladder) to form the common bile duct which then opens into the ... In cholecystectomy there is a slight risk (0.3-0.5%) of injury of the bile ducts, most commonly of the common bile duct. This ...
The pH of common duct bile (7.50 to 8.05) is higher than that of the corresponding gallbladder bile (6.80 to 7.65). Bile in the ... or other benign causes of bile duct narrowing. The most common cause of bile duct obstruction is when gallstone(s) are ... Serum immunoglobulin G4 in patients with nonmalignant common bile duct stricture. Menoufia Med J [serial online] 2021 [cited ... dislodged from the gallbladder into the cystic duct or common bile duct resulting in a blockage. A blockage of the gallbladder ...
"Bradshaw Lecture ON THE SURGERY OF THE GALL-BLADDER AND BILE-DUCTS". The Lancet. 214 (5543): 1075-1081. 23 November 1929. doi: ... Walton, James (1939). "Surgery of the Common Bileduct". Lancet. 234 (6068): 1253-1257. doi:10.1016/S0140-6736(00)74020-7. " ... Surgery of the Common Bileduct 1938 Sir Robert Ernest Kelly, Recurrent peptic ulceration, causes of, and design for second ... On the Surgery of the Gall Bladder and Bile Ducts 1928 Charles Herbert Fagge, Axial Rotation 1927 Cuthbert Sidney Wallace, A ...
Dixon, J. A.; Morgan, K. A.; Adams, D. B. (2009). "Management of common bile duct injury during partial gastrectomy". The ...
He pioneered the posterior approach to the common bile duct. Ong developed an academic framework in Hong Kong surgery, ...
The common bile duct is also temporarily closed during this procedure. This can be achieved using: a large atraumatic hemostat ...
The cystic duct attaches the gallbladder to the common bile duct. The spiral valves of Heister are supported by underlying ... Historically, physicians believed that their function was to aid in the passage of bile to and from the gallbladder, as well as ... The presence of the spiral folds, in combination with the tortuosity of the cystic duct, makes endoscopic cannulation and ... Miller, GL; Laurence, BH; McCarthy, JH (1989). "Cannulation of the cystic duct and gallbladder". Endoscopy. 21 (5): 223-4. doi: ...
Inflammation of the junction of the duodenum and common bile duct at the sphincter of Oddi is referred to as "odditis". Yamada ... Trancanelli, V (Feb 1993). "[Ruggero Oddi and the discovery of the common bile duct sphincter]". Minerva Med. Italy. 84 (1-2): ... described a small group of circular and longitudinal muscle fibers that wrapped around the end of the bile and pancreatic ducts ...
Common bile duct dilation and episodes of pancreatitis are also signs. Two mechanisms are involved in the development of ... or infections of the common bile duct. In contrast, dyskinesia of the sphincter of Oddi is a purely functional disorder, ... Functional disorders of the gallbladder, bile duct and pancreas have been defined and classified by the Rome criteria for ... The criteria outline three variants of functional disorders of the gallbladder, bile duct and pancreas, termed functional ...
"Intraoperative Cholangiography and Risk of Common Bile Duct Injury During Cholecystectomy". Lead Article, JAMA 2003;289:1639- ... Flum, DR, Cheadle, A, Prela, C, Dellinger, EP, Chan, L. "Bile Duct Injury During Cholecystectomy and Survival in Medicare ...
... and get stuck in the common bile duct. The common bile duct drains the liver and pancreas, and a blockage there can lead to ... Injury of the bile ducts can be prevented and treated by routinely using X-ray investigation of the bile ducts (intraoperative ... Laparoscopic cholecystectomy has a higher risk of bile duct injury than the open approach, with injury to bile ducts occurring ... Damage to the bile ducts is very serious because it causes leakage of bile into the abdomen. Signs and symptoms of a bile leak ...
Type I: Most common variety (80-90%) involving saccular or fusiform dilatation of a portion or entire common bile duct (CBD) ... Cholecystectomy with cystic duct ligation near the common bile duct is curative. Choledochal cysts are treated by surgical ... Choledochal cysts (a.k.a. bile duct cyst) are congenital conditions involving cystic dilatation of bile ducts. They are ... inflammation within the bile ducts caused by the spread of bacteria from the intestine into the bile ducts). Inflammation of ...
... and Urine After Ligation of the Common Bile Duct". Surgical Forum. 12: 337-339. ISSN 0071-8041. PMID 13860424. Hardy, James D ... "Lymphatic Transport of Bile Pigments and Alkaline Phosphatase in Experimental Common Duct Obstruction". Surgery. 52 (2): 366- ... Alican's official record of birth, 2 April 1930, is off by one year, a relatively common practice at the time by Turkish ...
The gastroduodenal artery, portal vein, and common bile duct lie just behind it. The distal part of the bulb is located ... Duodenal ulcers are more common than gastric ulcers and unlike gastric ulcers, are caused by increased gastric acid secretion. ...
The cystic duct leaves the gallbladder and joins with the common hepatic duct to form the common bile duct. This duct ... A common cause of blockage is a gallstone in the common bile duct. Thomas' sign is the production of silver stools and can be ... is formed by the union of the pancreatic duct and the common bile duct. The ampulla is specifically located at the major ... the sphincter of the pancreatic duct, the sphincter of the bile duct, and the sphincter of Oddi. The sphincter of Oddi controls ...
... The portal vein and its tributaries. The gall-bladder and bile ducts laid open. Common hepatic duct ... It joins the cystic duct coming from the gallbladder to form the common bile duct. The common hepatic duct is the first part of ... It then joins the cystic duct coming from the gallbladder to form the common bile duct. The duct is usually 6-8 cm long. The ... of people have additional accessory hepatic ducts that join onto the common hepatic duct. Rarely, the common hepatic duct joins ...
Common Bile Duct: Nondilated measuring 1.3 mm at the level of the porta hepatis. Pancreas: Visualized portions unremarkable. ... Liver Liver Liver Liver Liver Liver Liver Liver Liver Liver Liver Liver Liver Liver Gallbladder Gallbladder Bile duct Bile duct ... gallbladder or bile duct diseases, or a tumor in the liver. Ultrasonography of liver tumors involves two stages: detection and ... In cases of infectious mononucleosis, splenomegaly is a common symptom, and health care providers may consider using abdominal ...
In humans, it infects the common bile duct and gall bladder, feeding on bile. It was discovered by British physician James ... The free metacercariae penetrate the intestinal mucosa and enter the bile ducts. Migration into the bile ducts takes 1-2 days. ... bile duct obstruction, and even liver cirrhosis, cholangiocarcinoma, and hepatic carcinoma. As a major causative agent of bile ... Dwelling in the bile ducts, C. sinensis induces an inflammatory reaction, epithelial hyperplasia, and sometimes even ...
The sea cow had no gallbladder, but did have a wide common bile duct. Its anus was 10 cm (0.33 ft) in width, with its feces ... The sea cow may have also fed on seagrass, but the plant was not common enough to support a viable population and could not ... Wikimedia Commons has media related to Hydrodamalis gigas. Wikispecies has information related to Hydrodamalis gigas. Animal ... Commons link is on Wikidata, Articles with J9U identifiers, Articles with LCCN identifiers, Articles with NKC identifiers, ...
He was one of the first doctors to remove gallstones from the common bile duct. In 1890, Courvoisier published the book ...
Fellows, IW; Leach, IH; Smith, PG; Toghill, PJ; Doran, J (June 1990). "Carcinoid tumour of the common bile duct--a novel ...
While blood supply to the liver is left intact, the common bile duct is removed. This means that while the liver remains with a ... The shared blood supply of the pancreas, duodenum and common bile duct, necessitates en bloc resection of these multiple ... During the surgery, a new biliary connection (normally a choledochal-jejunal anastamosis connecting the common bile duct and ... damage to the common bile duct, pancreatic leakage, or transection of the duodenum. Due to the rarity of this procedure in the ...
Bile is secreted into the duodenum of the small intestine via the common bile duct. It is produced in liver cells and stored in ... Bile is formed of three elements: bile salts, bilirubin and cholesterol. Bilirubin is a waste product of the breakdown of ... The bile salt component is an active non-enzymatic substance that facilitates fat absorption by helping it to form an emulsion ... This is the result of the high concentration of both HCO3− and Na+ present in the duct creating an osmotic gradient to which ...
"Carcinoid tumour of the common bile duct--a novel complication of von Hippel-Lindau syndrome". Gut. 31 (6): 728-9. doi:10.1136/ ...
Halsted, William S. (1899). "The Contribution to the surgery of the bile passages, especially of the common bile-duct". The ... The conditions in the hospital were very unsanitary; bleeding patients was a common practice during this time, and surgical ...
... it remains an important landmark for surgeons performing cholecystectomy to avoid damaging the common bile duct. Calot's node ... Calot's triangle - isosceles triangle bounded by the common hepatic duct, the cystic duct and the cystic artery; ... 2003). "Causes and prevention of laparoscopic bile duct injuries: analysis of 252 cases from a human factors and cognitive ...
Horses, in common with mammals such as camels, do not have a gall bladder, meaning bile flows constantly. Most food is digested ... They have two ducts each, which open externally.[citation needed] The stallion's reproductive system is responsible for his ... Due to its many twists and turns, it is a common place for a type of horse colic called an impaction. The small colon is 3.0 to ... Bile from the liver aids in digesting fats in the duodenum combined with enzymes from the pancreas and small intestine. ...
... and bile duct proliferation/hyperplasia. Aspergillus flavus is a fungus of the family Trichocomaceae with a worldwide ... Aflatoxin B1 is a common contaminant in a variety of foods including peanuts, cottonseed meal, corn, and other grains; as well ... While aflatoxin B1 contamination is common in many staple foods, its production is maximized in foods stored in hot, humid ... Exposure is therefore most common in Southeast Asia, South America, and Sub-Saharan Africa. Aflatoxin B1 can permeate through ...
Other primary sites that have been reported include colon, rectum, stomach, gallbladder, bile ducts, small intestine, urinary ... Since the mucus tends to pool at the bottom of the abdominal cavity, it is common to remove the ovaries, fallopian tubes, ... It is slightly more common in women than men (male:female ratio of approximately 1:1.3,), although the actual ratio is ...
... or in the common bile duct (choledocholithiasis).: 977-978 Gallstones are a common cause of inflammation of the gallbladder, ... which secretes bile in order to aid digestion of fats. Diseases of the gallbladder and bile ducts are commonly diet-related, ... The most common condition of the oesophagus in Western countries is gastroesophageal reflux disease, which in chronic forms is ... Though less common, medications such as ACE inhibitors can cause angioedema and small bowel thickening. The small intestine ...
These include stomach disease, liver disease, pancreatic disease, gallbladder and bile duct disease; intestinal diseases ... However, the term is in common usage. In arthropods the abdomen is built up of a series of upper plates known as tergites and ... Wikimedia Commons has media related to Abdomen. "Abdomen" . Collier's New Encyclopedia. 1921. (CS1: long volume value, Articles ... is a common site of pain and tenderness in patients who have appendicitis. The fossa is named for the underlying iliac fossa of ...
High alkaline phosphatase levels can occur if the bile ducts are obstructed. Also, the level of alkaline phosphatase increases ... Some of the common genes found in this superfamily, are ones that encode phosphodiesterases as well as autotoxin. Acid ... bile duct, kidney, bone, intestinal mucosa and placenta. In the serum, two types of alkaline phosphatase isozymes predominate: ... Common alkaline phosphatases used in research include: Shrimp alkaline phosphatase (SAP), from a species of Arctic shrimp ( ...
The pancreatic duct joins the common bile duct just prior to the ampulla of Vater, after which both ducts perforate the medial ... The most common cause for obstruction is the presence of gallstones in the common bile duct, a condition called ... The pancreatic duct, or duct of Wirsung (also, the major pancreatic duct due to the existence of an accessory pancreatic duct ... is a duct joining the pancreas to the common bile duct. This supplies it with pancreatic juice from the exocrine pancreas, ...
The German professor Wilhelm Fabry believed that breast cancer was caused by a milk clot in a mammary duct. The Dutch professor ... Treatment was based on the humor theory of four bodily fluids (black and yellow bile, blood, and phlegm). According to the ... who discovered in 1775 that cancer of the scrotum was a common disease among chimney sweeps. The work of other individual ...
... which is the juncture of the pancreatic duct and the common bile duct, and is now referred to as the ampulla of Vater. In 1719 ...
The bile canaliculi empty into a series of progressively larger bile ductules and ducts, which eventually become common hepatic ... Bile canaliculus (plural:bile canaliculi; also called bile capillaries) is a thin tube that collects bile secreted by ... duct. The bile canaliculi empty directly into the Canals of Hering. Hepatocytes are polyhedral in shape, therefore having no ... Microvilli are present in the canaliculi.[citation needed] Bile+Canaliculi at the US National Library of Medicine Medical ...
... to give the common bile duct. This duct then enters the duodenum at the ampulla of Vater. In cholestasis, bile accumulates in ... involving bile duct injury), or vanishing bile duct syndrome (loss of intrahepatic bile ducts).: 17 Bland cholestasis occurs ... If bile stones are present in the common bile duct, an endoscopic sphincterotomy can be conducted either with or without ... Later, the endoscopist can place a stent in the common bile duct to soften any remaining stones and allow for bile drainage. If ...
A drug excreted in the bile duct can occasionally be reabsorbed by the intestines (in the enterohepatic circuit), which can ... An example of this is shown in the following table for the CYP1A2 enzyme, which is the most common enzyme found in the human ... Bile excretion of drugs mainly takes place where their molecular weight is greater than 300 and they contain both polar and ... Bile excretion is different from kidney excretion as it always involves energy expenditure in active transport across the ...
Cholangiocarcinoma is a rare form of cancer that forms in bile ducts, which are slender tubes that carry the digestive fluid ... Additional common adverse reactions include rash, anemia, epistaxis, serous retinal detachment, extremity pain, dyspepsia, ... Pemigatinib, sold under the brand name Pemazyre, is an anti-cancer medication used for the treatment of bile duct cancer ( ... "FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts". U.S. Food and Drug ...
... and extending upward along the common bile duct, between the two layers of the lesser omentum, as far as the porta hepatis; the ... A particularly large hepatic artery lymph node, positioned on the anterior aspect of the common hepatic artery, is thought to ... Cordera, Fernando; Arciero, Cletus A.; Li, Tianyu; Watson, James C.; Hoffman, John P. (August 2007). "Significance of common ...
Serum alanine aminotransferase (ALT) was increased in several animals, while in a dog a proliferation of bile ducts was ... Unlike other coccidiostats, nicarbazin rarely presents resistance phenomena towards the most common coccidioses such as those ...
For example, elevated ALT levels due to hepatocyte damage can be distinguished from bile duct problems by measuring alkaline ... ALT is found in plasma and in various body tissues but is most common in the liver. It catalyzes the two parts of the alanine ... bile duct problems, infectious mononucleosis, or myopathy, so ALT is commonly used as a way of screening for liver problems.[ ...
Fibrocystin is found in the epithelial cells of both the renal tubule and the bile ducts; deficiency leads to the ... This is suggesting a common mechanism underlying cystogenesis between ADPKD and ARPKD. The FPC protein is also found on the ... is found on the primary cilia of epithelia cells of cortical and medullary collecting ducts and cholangiocytes of bile ducts, ...
FREM1 Bile acid malabsorption, primary; 613291; SLC10A2 Bile acid synthesis defect, congenital, 2; 235555; AKR1D1 Bile acid ... common variable, 1; 607594; ICOS Immunodeficiency, common variable, 2; 240500; TNFRSF13B Immunodeficiency, common variable, 3; ... DCTN1 Persistent Mullerian duct syndrome, type I; 261550; AMH Persistent Mullerian duct syndrome, type II; 261550; AMHR2 ... 613493; CD19 Immunodeficiency, common variable, 4; 613494; TNFRSF13C Immunodeficiency, common variable, 5; 613495; MS4A1 ...
... interlobular bile ducts >> left and right hepatic ducts These merge to form the common hepatic duct The common hepatic duct ... The common bile duct, commonly abbreviated CBD, is formed by the union of the cystic duct and common hepatic duct, and it later ... Bile is secreted by the liver into small ducts that join to form the common hepatic duct. Between meals, secreted bile is ... The function of the common bile duct is to allow bile to travel from the gallbladder to the small intestine, mixing with ...
Other causes of KF rings are cholestasis (obstruction of the bile ducts), primary biliary cirrhosis and "cryptogenic" cirrhosis ... cirrhosis in which no cause can be identified). As Kayser-Fleischer rings do not cause any symptoms, it is common for them to ...
... stomach and bile duct. Marshall SF, Polk RC (1958). "Spontaneous internal biliary fistulas". Surg Clin North Am. 38 (3): 679-91 ... It is a common finding in patients that have recently undergone biliary surgery or endoscopic biliary procedure. While the ...
Wikimedia Commons has media related to Omeprazole. "Omeprazole". Drug Information Portal. U.S. National Library of Medicine. ... primarily originating from bile secretion. Omeprazole has a half life of 0.5 to 1 hour. The pharmacological effects of ... indicating that a little amount of drug is transferred to the milk duct during breast milk formation. Omeprazole needs to be ... Common side effects include nausea, vomiting, headaches, abdominal pain, and increased intestinal gas. Serious side effects may ...
It produces considerable quantities of bile acids for use in the intestines; these are carried to the intestines via ducts and ... it is the most common genetic diseases in those of Northern European ancestry. It is less common in other populations. See: ... Infection is one, duct blockage is another. Peak action The time period when the effect of something is as strong as it can be ... It is common in diabetic men, due to damage to the nerves involved in the erection sequence, and possibly due to microvascular ...
... to drain the common bile duct of obstruction. In addition to this, Soehendra developed a novel and now commonly used technique ... for dilation of strictures of the common bile duct; the mechanical lithotripter used to crush gallstones in the biliary system ... Soehendra N, Reynders-Frederix V (1980). "Palliative bile duct drainage - a new endoscopic method of introducing a ...
Mild to moderate bile duct proliferation may also be present. On radiology, the liver may be shrunken and difficult to ... It is one of the most common cause of acute hepatitis and liver failure in the horse. There is a rapid onset of clinical signs ... In the Northern hemisphere it is most common between August to November. It is seen almost exclusively in adult horses, and ... It has a mottled and bile stained surface. On microscopy there is marked centrilobular to midzonal hepatocellular necrosis and ...
MeSH A03.159.183.079 - extrahepatic bile ducts MeSH A03.159.183.079.300 - common bile duct MeSH A03.159.183.079.300.950 - ... common hepatic duct MeSH A03.159.183.158 - intrahepatic bile ducts MeSH A03.159.183.158.125 - bile canaliculi MeSH A03.556. ... salivary ducts MeSH A03.556.500.760.650 - minor salivary glands MeSH A03.556.500.760.687 - sublingual gland MeSH A03.556. ... bile canaliculi MeSH A03.734.414.065 - glucagon-secreting cells MeSH A03.734.414.131 - insulin-secreting cells MeSH A03.734. ...
Notify me when Mayo Clinic Laparoscopic Transcystic Common Bile Duct Exploration Symposium 2023 registration opens. ...
HomeSurgical InstrumentsGall, Liver, Kidney, Bladder, UrologyCommon Bile Duct Dilators BAKES Common Bile Duct Dilators. ... BAKES Common Bile Duct Dilators Ak-2186-01 , Ak-2186-02 , Ak-2186-03 , Ak-2186-04 , Ak-2186-05 , Ak-2186-06 , Ak-2186-07 , Ak- ... Be the first to review "BAKES Common Bile Duct Dilators" Cancel reply. Your email address will not be published. Required ...
Unnecessary endoscopic retrograde cholangiopancreatography (ERCP) after spontaneous passage of common bile duct stones (CBDSs) ... Unnecessary endoscopic retrograde cholangiopancreatography associated with the spontaneous passage of common bile duct stones ... and nondilated common bile duct (< 10 mm) were the significant factors associated with spontaneous CBDS passage. Specifically, ...
Bile duct obstruction is a blockage in the tubes that carry bile from the liver to the gallbladder and small intestine. ... Recent biliary cancer (such as bile duct cancer) The blockage can also be caused by infections. This is more common in people ... Bile salts help your body break down (digest) fats. Bile passes out of the liver through the bile ducts and is stored in the ... When the bile ducts become blocked, bile builds up in the liver, and jaundice (yellow color of the skin) develops due to the ...
CBD: common bile duct; LAMS: lumen-apposing metal stent. Patients with periampullary malignancies may present biliary ... The bile duct was punctured from the duodenal bulb using a 19-G needle through the mesh of the central segment of SEMS under ... EUS revealed a 17-mm dilated bile duct so a EUS-guided choledochoduodenostomy (EUS-CDS) through the SEMSs was attempted. ... A computed tomography scan showed distal biliary obstruction and retrograde dilatation of the bile duct. With a gastroscope, ...
Laparoscopic Common Bile Duct Exploration: Our First 50 Cases. Ker-Kan Tan, Vishalkumar Girishchandra Shelat, Kui-Hin Liau, ... Head injuries are common childhood injuries that present to paediatric emergency departments. Falls are the most common cause ... The most common causes of morbidity in adolescence often have behavioural or social determinants, and can have enormous social ... Retinal and Cardiovascular Diseases: The "Common Soil" Theory. Tien Y Wong There is increasing evidence that retinal and ...
We measured the viscosity of bile from the common bile duct during endoscopic retrograde cholangiography. Bile was aspirated ... We conclude that bile viscosity in the common bile duct is usually lower than that of plasma, in 15% it is higher and increases ... Cholecystectomized patients had a lower bile viscosity. Bile viscosities did not differ between patient groups with either ... Little is known about bile viscosity, a major determinant of its flow. ...
The ultra sound describes it as follows: Bile ducts: No significant dilation. Common bile duct mea.... Started by boncela. Last ...
Ninety percent of cases involve stones in the cystic duct (ie, calculous cholecystitis), with the other 10% of cases ... is defined as inflammation of the gallbladder that occurs most commonly because of an obstruction of the cystic duct from ... allows visualization of the anatomy and can provide therapy by removing stones from the common bile duct. ... If bile duct injury occurs, the patient should be referred to an experienced hepatobiliary specialist before any repair is ...
... and dilatation and stricturing of the intrahepatic and extrahepatic bile duct. Digby published the first detailed English- ... common bile duct dilation (68%), pneumobilia (52%), hepatic segmental atrophy (36%), common bile duct calculi (30%), bile duct ... Sherman and Lehman reported inability to cannulate the common bile duct in 5-10% of attempted ERCP studies. [19] ... This approach may cause contrast material to reflux into the common bile duct, thus confounding study findings. ...
B) Drawing of A; depicted are the liver (white), the common bile duct (gray), and... ... B) Drawing of A; depicted are the liver (white), the common bile duct... ... and flukes could be visualized by ultrasound in the gallbladder and common bile duct (Figure). Thereafter, the patient was ... that live in the bile ducts of the final host are excreted in the feces and develop into larvae (miracidia) in water. The ...
... and a normal or stenotic distal common bile duct. Cholangiography may reveal beading of the common bile duct or papillary ... Dilated or irregular intrahepatic and extrahepatic bile ducts, along with a thickened gallbladder, as detected with abdominal ... Liver biopsy findings may reveal the organism attached to bile duct epithelial cells. Concurrent infection with cytomegalovirus ... ERCP identification of Cryptosporidium oocysts in bile or intracellular forms on biopsy confirms the diagnosis of biliary ...
Endoscopic retrograde cholangiopancreatography (ERCP) was performed, which demonstrated a live parasite in the common bile duct ... the normal location in the host is the pancreas and this is very rarely present in the bile duct. ...
Diffuse common bile duct mural thickening in a patient with pancreatitis.. Gastroenterology. 2022 Jun 15. pii: S0016-5085(22) ... Common genetic variants in the bile acid synthesis enzyme CYP7A1 are associated with severe primary bile acid diarrhea.. ... Bile duct stricture at the superior margin of pancreas.. Gastroenterology. 2022 Jun 4. pii: S0016-5085(22)00601.. PubMed * ... Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?. ...
Incision of bile duct for relief of obstruction. 51.41 Common duct exploration for removal of calculus ... Local excision or destruction of lesion or tissue of biliary ducts and sphincter of Oddi ... Endoscopic Excision Or Destruction Of Lesion Of Biliary Ducts Or Sphincter Of Oddi ... Other Excision Or Destruction Of Lesion Or Tissue Of Pancreas Or Pancreatic Duct ...
Phylloerythrin has been incriminated as the phototoxic agent in the following conditions: common bile duct occlusion; facial ... Failure to excrete phylloerythrin due to hepatic dysfunction or bile duct lesions increases the amount in the circulation. Thus ... Secondary (type III) photosensitization caused by abnormal hepatic metabolism of phylloerythrin is the most common type seen in ... is normally absorbed into the circulation and is effectively excreted by the liver into the bile. ...
Pasireotide has many side effects including suppression of gall bladder contractility and bile production, and maintenance ... Even after cholecystectomy, cholesterol stones may form in the common bile duct and intrahepatic ducts during somatostatin ... Side effects are common. Adverse events from single injections include influenza-like symptoms of fatigue, headache, nausea and ... How infusions of pasireotide might cause acute liver injury independent of its effect on bile flow and gall bladder function is ...
"Double-blind placebo-controlled ultrasonographic confirmation of constriction of the common bile duct by morphine." Int J Clin ...
Bile is released from the gallbladder into the small intestine in response to food. The pancreatic duct joins the common bile ... Bile is released from the gallbladder into the small intestine in response to food. The pancreatic duct joins the common bile ... To do this test, dye is injected into your common bile duct and an x-ray is taken. The dye helps find stones that may be ... A percutaneous transhepatic cholangiogram (PTC) is an x-ray of the bile ducts. These are the tubes that carry bile from the ...
But is there not a good reason? Gallbladders collect gallstones, which can block the common bile duct and lead to pancreatic ... Bile, bile salts, cholecystectomy, Gallbladder, gallbladder removal, Gallstones, Liver, Maloney, post cholecystectomy syndrome ... Synthetic bile salts are also available, but the research findings on ox bile for the dissolution of gallstones are better than ... Use of bile salts. The use of bile salts, specifically ursodiol, is now considered less effective than gallbladder removal ...
Perforation is more common with an additional pathology present such as hernias or diverticular disease. Migration and ... perforation also appear more common with straight biliary stents. In patients with known diverticular disease and straight ... and stents were placed in the common bile duct. CT scan of the abdomen and pelvis demonstrated a biliary stent that had ... and stents were placed in the common bile duct. CT scan of the abdomen and pelvis demonstrated a biliary stent that had ...
No intra or extrahepatic biliary dilation, with the common bile duct measuring less than 4 mm. No strictures or filling defects ... The common duct measures 2.6 mm.. Flow is evident in the main portal vein which is normal in size. No splenic or renal ...
Anastomosis Of Small Intestine To Common … exh26217b-nl Image Anastomosis Of Small Intestine To Common Bile Duct. This stock ... Anastomosis Of Small Intestine To Common … exh26217b Image Anastomosis Of Small Intestine To Common Bile Duct. This stock ... Anastomosis Of Small Intestine To Common … Image ... Anastomosis Of Small Intestine To Common … Image ...
Skar V., Skar A. G., Stromme J. H. β-Glucuronidase activity related to bacterial growth in common bile duct bile in gallstone ... In a few patients, CPT-11 and SN-38 concentrations in bile have been measured (20, 24, 25, 100). CPT-11, SN-38, and SN-38G ... NPC was also detected in bile at very low concentrations (80). In a female patient, carrying a biliary T-tube and receiving ... Several studies have examined the excretion of CPT-11 in bile, feces, and urine in animals and humans. In humans, only 52% of ...
portal vein, hepatic artery and common bile duct * Define Ascites. Give examples of it. ... What are some common gastric pathologies and their causes? Erosive gastritis: NSAIDs or Alcohol, Ulceration: secondary to ...
... of the pancreas usually cant really be removed without removing a significant portion of the duodenum and the common bile duct ... I make the analogy to adenocarcinoma of the pancreas, the much more lethal pancreatic cancer that is far more common than the ...
... long distance common bile duct (CBD)-transducer, or intervening vessels). The extrahepatic bile duct will be identified by ... with direct access to the bile duct, and (ii) classic technique, with initial puncture of the extrahepatic bile duct using a 19 ... has been demonstrated to improve LAMS patency and bile flow, by maintaining a vertical orientation in the bile duct. But a ... BRI is defined as the need to perform a new therapeutic maneuver on the bile duct due to RBO. A distinction must be made ...
  • Recurrent pyogenic cholangitis is characterized primarily by hepatolithiasis within the intrahepatic and extrahepatic bile ducts. (medscape.com)
  • When indicated, as guided by symptoms, ultrasonography or CT scanning may reveal an enlarged gallbladder with a thickened wall, dilated or irregular intrahepatic and extrahepatic biliary ducts, and a normal or stenotic distal common bile duct. (medscape.com)
  • No intra or extrahepatic biliary dilation, with the common bile duct measuring less than 4 mm. (radiopaedia.org)
  • These include malignant melanoma of the skin, colorectal cancer, cancer of the gallbladder and extrahepatic bile ducts, and pituitary tumours. (who.int)
  • Bile duct obstruction is a blockage in the tubes that carry bile from the liver to the gallbladder and small intestine. (medlineplus.gov)
  • Bile passes out of the liver through the bile ducts and is stored in the gallbladder. (medlineplus.gov)
  • Fogel EL, Sherman S. Diseases of the gallbladder and bile ducts. (medlineplus.gov)
  • IgG titers remained positive (320, by enzyme immunoassay), and flukes could be visualized by ultrasound in the gallbladder and common bile duct ( Figure ). (cdc.gov)
  • liver, the gallbladder and/or related ducts. (who.int)
  • The gallbladder is part of a network of structures known collectively as the biliary tree, which drains bile from the liver into the duodenum to facilitate digestion. (cdc.gov)
  • The function of the gallbladder is to provide a reservoir for the storage and concentration of bile. (cdc.gov)
  • The surgeon cuts the bile duct and blood vessels that lead to the gallbladder. (adam.com)
  • These are the tubes that carry bile from the liver to the gallbladder. (adam.com)
  • The most common way to remove the gallbladder is by using a medical instrument called a laparoscope ( laparoscopic cholecystectomy ). (adam.com)
  • Gallbladder removal surgery (cholecystectomy) is the only surgical procedure so common that my patients consistently forget to list it in their medical records. (ndnr.com)
  • The use of bile salts, specifically ursodiol, is now considered less effective than gallbladder removal because of the possibility of gallstone recurrence. (ndnr.com)
  • Usually the cystic artery arises from the right hepatic artery, passing behind the common hepatic and cystic duct in the Calot triangle, to reach the upper surface of the neck of the gall bladder, where it divides into superficial and deep branches [6,7]. (who.int)
  • tery, passing behind the common hepatic and The anatomy of the cystic artery and the cystic duct in the Calot triangle, to reach the extrabiliary ducts were examined. (who.int)
  • Bile is a liquid released by the liver. (medlineplus.gov)
  • When the bile ducts become blocked, bile builds up in the liver, and jaundice (yellow color of the skin) develops due to the increasing level of bilirubin in the blood. (medlineplus.gov)
  • depicted are the liver (white), the common bile duct (gray), and. (cdc.gov)
  • After ingestion by the host, they excyst in the intestine and migrate through the intestinal wall to the liver, where they mature into adult flatworms that reside in the bile ducts ( 2 ). (cdc.gov)
  • Response to Letter to Editor: Bile and Liver in Pregnancy: no one Split apart what God has Joined Together. (amedeo.com)
  • Secreted by the liver, bile is composed largely of bile salts, bile pigments and small amounts of organic materials such as cholesterol, lecithin, fatty acid and mucin. (cdc.gov)
  • Bile salts are produced by the liver and are essential for the digestion and absorption of fat in the small intestine. (cdc.gov)
  • Ms. Doe was transferred to another facility where she underwent emergency surgery to repair injuries to her common bile duct, the hepatic duct and right hepatic artery. (robertkreisman.com)
  • A computed tomography scan showed distal biliary obstruction and retrograde dilatation of the bile duct. (lww.com)
  • It contains cholesterol, bile salts, and waste products such as bilirubin . (medlineplus.gov)
  • Bile salts help your body break down (digest) fats. (medlineplus.gov)
  • 2000 for 20 years' supply of bile salts at retail). (ndnr.com)
  • Patients with larger stones can undergo lithotripsy to break them up and then follow up with bile salts to avoid recurrence. (ndnr.com)
  • 5 A small percentage of these patients have had botched operations and/or generate stone crystals in the bile duct (which resolve with the addition of bile salts). (ndnr.com)
  • An Unusual cause of localized dilatation of bile duct. (amedeo.com)
  • Gallbladders collect gallstones, which can block the common bile duct and lead to pancreatic and hepatic inflammation. (ndnr.com)
  • the most common tumor types were cholangiocarcinoma (bile duct cancer) (n=31), high-grade glioma (tumor of the brain or spinal cord) (n=29), breast cancer (n=14), pancreatic cancer (n=13) and squamous non-small cell lung cancer (n=11). (jnj.com)
  • Fluoroscopic and endoscopic views verified correct placement as bile flows into the gastrointestinal tract through the LAMS [ Figure 1 ]. (lww.com)
  • The insertion of a coaxial double-pigtail plastic stent (DPS) has been demonstrated to improve LAMS patency and bile flow, by maintaining a vertical orientation in the bile duct. (biomedcentral.com)
  • It consists of a rounded fundus, smooth body and tapering neck, which becomes contiguous with the cystic duct and attaches to the porta hepatis. (cdc.gov)
  • Unnecessary endoscopic retrograde cholangiopancreatography ( ERCP ) after spontaneous passage of common bile duct stones (CBDSs) should be avoided. (bvsalud.org)
  • In the multivariate analysis , CBDS sized diagnostic imaging , solitary CBDS on diagnostic imaging , intervals between the imaging diagnosis and ERCP , and nondilated common bile duct ( (bvsalud.org)
  • Endoscopic retrograde cholangiopancreatography (ERCP) was performed, which demonstrated a live parasite in the common bile duct. (cdc.gov)
  • She had undergone an ERCP four weeks previously for primary choledocholithiasis during which time a sphincterotomy and sphincteroplasty were performed, and stents were placed in the common bile duct. (hindawi.com)
  • She had undergone an ERCP four weeks previously for primary choledocholithiasis during which time a sphincterotomy and sphincteroplasty were performed, and a 10 Fr stent with internal and external flaps and a 7 Fr stent with internal and external pigtails were placed in the common bile duct. (hindawi.com)
  • Unnecessary endoscopic retrograde cholangiopancreatography associated with the spontaneous passage of common bile duct stones into the duodenum: a multicenter retrospective study. (bvsalud.org)
  • The biliary tree also includes the cystic duct, the right and left hepatic ducts, and the common hepatic and common bile ducts, as well as a series of microscopic biliary vessels. (cdc.gov)
  • This study documents variations in the origin of the cystic artery and its location in relation to the biliary ducts among 106 Sudanese people and compared the variations between the sexes and races. (who.int)
  • Anatomical study of the cystic artery is important because its origin from the nearby vessels and because its relation to the biliary ducts is very variable, creating potential difficulties during surgery [1-5]. (who.int)
  • The aim of this study was to record the variations in origin of the cystic artery from different sources and its location in relation to the biliary ducts among Sudanese people and to compare the variations between the sexes and different races. (who.int)
  • It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT. (bvsalud.org)
  • however, the normal location in the host is the pancreas and this is very rarely present in the bile duct. (cdc.gov)
  • Pasireotide has many side effects including suppression of gall bladder contractility and bile production, and maintenance therapy can cause cholelithiasis and accompanying elevations in serum enzymes and bilirubin. (nih.gov)
  • It passes in front of or behind the bile duct or the common hepatic duct to reach the neck of the gall bladder. (who.int)
  • It passes in location between different races were also front of or behind the bile duct or the com- noted and compared with data from other mon hepatic duct to reach the neck of the gall studies. (who.int)
  • The most common types of cancer diagnosed were breast (17 cases), lung (7 cases), and prostate (4 cases), which are the three most common cancers in the United States. (cdc.gov)
  • It stores bile, which your body uses to digest fats in the small intestine. (adam.com)
  • Cette étude a mis en évidence les variations au niveau de la naissance de l'artère cystique et de sa localisation par rapport aux voies biliaires chez 106 sujets soudanais et a comparé ces variations entre les sexes et les races. (who.int)
  • Eggs of the adult worms (2-4 cm) that live in the bile ducts of the final host are excreted in the feces and develop into larvae (miracidia) in water. (cdc.gov)
  • Be aware of any risk factors you have, so that you can get prompt diagnosis and treatment if a bile duct becomes blocked. (medlineplus.gov)
  • Endoscopic placement of plastic biliary stents for benign biliary disease has become a common procedure. (hindawi.com)
  • The surgeon converted to an open procedure where it was revealed that Ms. Doe's common bile duct had been clipped and transected. (robertkreisman.com)
  • If the blockage is caused by cancer, the duct may need to be widened. (medlineplus.gov)
  • For women over the age of 45, when breast cancer becomes more common, the report found no evidence of an increased risk of breast cancer associated with prior use of oral contraceptives. (who.int)
  • Gastroesophageal reflux disease (GERD), a common problem in infancy, may lead to troublesome symptoms or complications such as oesophagitis or oesophageal stricturing in a. (annals.edu.sg)
  • Elimination routes of CPT-11 also depend on the presence of drug-transporting proteins, notably P-glycoprotein and canalicular multispecific organic anion transporter, present on the bile canalicular membrane. (aacrjournals.org)
  • Perforation is more common with an additional pathology present such as hernias or diverticular disease. (hindawi.com)
  • Bile pigments are the end product of the breakdown of hemoglobin during the destruction of old red blood cells. (cdc.gov)
  • 3%). No cases arising from other arteries to the biliary ducts among Sudanese people were noted. (who.int)
  • 1 Despite the evidence of recurrence, the NIH was reluctant to recommend maintenance bile salt therapy. (ndnr.com)
  • Acute cholangitis (AC) is a common emergency with significant mortality risk. (medscape.com)
  • This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (lww.com)
  • Mass treatment of sheep and cattle with TCBZ (Fasinex) or in combination with other anthelmintic drugs is common in the Netherlands (L. Moll, pers. (cdc.gov)
  • Civil Hospital, Soba University Hospital ducts is very variable, creating potential dif- and Omdurman Civil Hospital. (who.int)
  • He has written a book titled „Common bile duct exploration : Experiences and a study published by Lambert Academic Publishing - 2011 (ISBN 978-3-8454-3056-0, paper book, 80 pages). (amu.ac.in)
  • Hypoglycaemia complicates many common childhood illnesses seen in the emergency room and is associated with significant mortality. (bvsalud.org)
  • This is more common in people with weakened immune systems. (medlineplus.gov)